Document and Entity Information
Document and Entity Information | 12 Months Ended |
Dec. 31, 2022 shares | |
Entity Registrant Name | Fiverr International Ltd. |
Entity Central Index Key | 0001762301 |
Current Fiscal Year End Date | --12-31 |
Document Fiscal Year Focus | 2022 |
Document Fiscal Period Focus | FY |
Amendment Flag | false |
Document Registration Statement | false |
Document Type | 20-F |
Document Annual Report | true |
Document Transition Report | false |
Document Shell Company Report | false |
Document Period End Date | Dec. 31, 2022 |
Entity File Number | 001-38929 |
Entity Incorporation State Country Code | L3 |
Entity Address, Address Line One | 8 Eliezer Kaplan St |
Entity Address, City or Town | Tel Aviv |
Entity Address, Country | IL |
Entity Address, Postal Zip Code | 6473409 |
Title of 12(b) Security | Ordinary shares, no par value |
Trading Symbol | FVRR |
Name of Exchange on which Security is Registered | NYSE |
Entity Well-known Seasoned Issuer | Yes |
Entity Voluntary Filers | No |
Entity Current Reporting Status | Yes |
Entity Interactive Data Current | Yes |
Entity Filer Category | Large Accelerated Filer |
Entity Emerging Growth Company | false |
Auditor Attestation Flag | true |
Document Accounting Standard | U.S. GAAP |
Entity Shell Company | false |
Entity Common Stock, Shares Outstanding | 37,537,563 |
Auditor Name | KOST FORER GABBAY & KASIERER |
Auditor Location | Israel |
Auditor Firm ID | 1281 |
Business Contact | |
Contact Personnel Name | Micha Kaufman |
Entity Address, Address Line One | 8 Eliezer Kaplan St |
Entity Address, City or Town | Tel Aviv |
Entity Address, Country | IL |
Entity Address, Postal Zip Code | 6473409 |
City Area Code | 972 |
Local Phone Number | 72-2280910 |
Consolidated balance sheets
Consolidated balance sheets - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Current assets: | ||
Cash and Cash Equivalents, at Carrying Value | $ 86,752 | $ 71,151 |
Restricted cash | 1,137 | 2,919 |
Marketable securities | 241,293 | 118,150 |
User funds | 143,020 | 127,713 |
Bank deposits | 134,000 | 134,000 |
Other receivables | 19,019 | 14,285 |
Total current assets | 625,221 | 468,218 |
Marketable securities | 189,839 | 317,524 |
Property and equipment, net | 5,660 | 6,555 |
Operating lease right-of-use assets, net | 9,077 | 11,727 |
Intangible assets, net | 14,770 | 49,221 |
Goodwill | 77,270 | 77,270 |
Other non-current assets | 1,965 | 1,055 |
Total assets | 923,802 | 931,570 |
Current liabilities: | ||
Trade payables | 8,630 | 8,699 |
User accounts | 133,032 | 118,616 |
Deferred revenue | 11,353 | 12,145 |
Other account payables and accrued expenses | 41,328 | 44,260 |
Operating lease liabilities | 2,755 | 3,055 |
Current maturities of long-term loan | 0 | 2,269 |
Total current liabilities | 197,098 | 189,044 |
Long-term liabilities: | ||
Convertible notes | 452,764 | 372,076 |
Operating lease liabilities | 6,649 | 10,483 |
Long-term loan and other non-current liabilities | 1,559 | 13,099 |
Total long-term liabilities | 460,972 | 395,658 |
Total liabilities | 658,070 | 584,702 |
Commitments and contingencies (see note 11) | ||
Shareholders' equity: | ||
Shares authorized: 75,000,000 ordinary shares with no par value as of December 31, 2022 and 2021 Shares issued and outstanding: 37,537,563 and 36,761,108 ordinary shares as of December 31, 2022 and 2021, respectively | 0 | 0 |
Additional paid-in capital | 565,834 | 585,548 |
Accumulated deficit | (288,039) | (237,585) |
Accumulated other comprehensive loss | (12,063) | (1,095) |
Total shareholders' equity | 265,732 | 346,868 |
Total liabilities and shareholders' equity | $ 923,802 | $ 931,570 |
Consolidated balance sheets (Pa
Consolidated balance sheets (Parenthetical) - $ / shares | Dec. 31, 2022 | Dec. 31, 2021 |
Statement of Financial Position [Abstract] | ||
Ordinary shares, authorized | 75,000,000 | 75,000,000 |
Ordinary shares, par value | $ 0 | $ 0 |
Ordinary shares, issued | 37,537,563 | 36,761,108 |
Ordinary shares, outstanding | 37,537,563 | 36,761,108 |
Consolidated statements of oper
Consolidated statements of operations - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Income Statement [Abstract] | |||
Revenue | $ 337,366 | $ 297,662 | $ 189,510 |
Cost of revenue | 65,948 | 51,723 | 33,188 |
Gross profit | 271,418 | 245,939 | 156,322 |
Operating expenses: | |||
Research and development | 92,563 | 79,298 | 45,719 |
Sales and marketing | 174,599 | 159,365 | 94,379 |
General and administrative | 51,161 | 52,616 | 28,034 |
Impairment of intangible assets | 27,629 | 0 | 0 |
Total operating expenses | 345,952 | 291,279 | 168,132 |
Operating loss | (74,534) | (45,340) | (11,810) |
Financial income (expenses), net | 3,624 | (19,513) | (2,800) |
Loss before income taxes | (70,910) | (64,853) | (14,610) |
Effective income taxes | (577) | (159) | (200) |
Net loss | $ (71,487) | $ (65,012) | $ (14,810) |
Basic net loss per share attributable to ordinary shareholders | $ (1.94) | $ (1.81) | $ (0.46) |
Diluted net loss per share attributable to ordinary shareholders | $ (1.94) | $ (1.81) | $ (0.46) |
Basic weighted average ordinary shares | 36,856,140 | 35,955,014 | 32,323,636 |
Diluted weighted average ordinary shares | 36,856,140 | 35,955,014 | 32,323,636 |
Consolidated statements of comp
Consolidated statements of comprehensive loss - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Income Statement [Abstract] | |||
Net loss | $ (71,487) | $ (65,012) | $ (14,810) |
Marketable securities: | |||
Unrealized gain (loss) | (8,865) | (2,129) | 158 |
Derivatives: | |||
Unrealized income (loss) | (7,060) | 1,662 | 1,403 |
Amounts reclassified from accumulated other comprehensive loss | 4,957 | (1,160) | (1,267) |
Other comprehensive income (loss) | (10,968) | (1,627) | 294 |
Comprehensive loss | $ (82,455) | $ (66,639) | $ (14,516) |
Consolidated statements of shar
Consolidated statements of shareholders' equity - USD ($) $ in Thousands | Number of ordinary shares and protected ordinary shares | Share capital and additional paid-in capital | Accumulated deficit | Accumulated other comprehensive income (loss) | Total |
Balance at Dec. 31, 2019 | $ 306,334 | $ (157,763) | $ 238 | $ 148,809 | |
Balance, shares at Dec. 31, 2019 | 31,937,772 | ||||
Share-based compensation | 15,855 | 0 | 0 | 15,855 | |
Exercise of share options, vested RSUs and ESPP | 9,452 | 0 | 0 | 9,452 | |
Exercise of share options, vested RSUs and ESPP (shares) | 1,605,208 | ||||
Issuance of ordinary shares in connection with follow on offering, net of issuance costs | 129,853 | 0 | 0 | 129,853 | |
Issuance of ordinary shares in connection with follow on offering, net of issuance costs (shares) | 2,300,000 | ||||
Equity component of convertible notes, net of issuance costs | 99,190 | 0 | 0 | 99,190 | |
Purchase of capped call | (43,240) | 0 | 0 | (43,240) | |
Net loss | 0 | (14,810) | 0 | (14,810) | |
Other comprehensive income | 0 | 0 | 294 | (294) | |
Balance at Dec. 31, 2020 | 517,444 | (172,573) | 532 | 345,403 | |
Balance, shares at Dec. 31, 2020 | 35,842,980 | ||||
Share-based compensation | 55,654 | 0 | 0 | 55,654 | |
Exercise of share options, vested RSUs and ESPP | 12,137 | 0 | 0 | 12,137 | |
Exercise of share options, vested RSUs and ESPP (shares) | 918,128 | ||||
Equity awards assumed for acquisition | 313 | 0 | 0 | 313 | |
Net loss | 0 | (65,012) | 0 | (65,012) | |
Other comprehensive income | 0 | 0 | (1,627) | (1,627) | |
Balance at Dec. 31, 2021 | 585,548 | (237,585) | (1,095) | 346,868 | |
Balance, shares at Dec. 31, 2021 | 36,761,108 | ||||
Share-based compensation | 72,029 | 0 | 0 | 72,029 | |
Exercise of share options, vested RSUs and ESPP | 7,447 | 0 | 0 | $ 7,447 | |
Exercise of share options, vested RSUs and ESPP (shares) | 776,455 | 282,479 | |||
Cumulative effect of adopting ASU | (99,190) | 21,033 | 0 | $ (78,157) | |
Net loss | 0 | (71,487) | 0 | (71,487) | |
Other comprehensive income | 0 | 0 | (10,968) | (10,968) | |
Balance at Dec. 31, 2022 | $ 565,834 | $ (288,039) | $ (12,063) | $ 265,732 | |
Balance, shares at Dec. 31, 2022 | 37,537,563 |
Consolidated statements of sh_2
Consolidated statements of shareholders' equity (Parenthetical) $ in Thousands | 12 Months Ended |
Dec. 31, 2020 USD ($) | |
Statement of Stockholders' Equity [Abstract] | |
Ordinary shares issuance costs | $ 1,109 |
Convertible notes issuance costs | $ 2,842 |
Consolidated statements of cash
Consolidated statements of cash flows - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Cash flows from operating activities: | |||
Net loss | $ (71,487) | $ (65,012) | $ (14,810) |
Adjustments to reconcile net loss to net cash provided by operating activities: | |||
Depreciation and amortization | 10,185 | 6,876 | 4,338 |
Amortization of premium and discount of marketable securities, net | 6,385 | 7,903 | 1,091 |
Amortization of discount and issuance costs of convertible notes | 2,527 | 20,029 | 4,036 |
Share -based compensation | 71,755 | 55,407 | 15,815 |
Net loss (gain) from exchange rate fluctuations | 31 | 242 | (1,076) |
Impairment of intangible assets | 27,629 | 0 | 0 |
Loss from disposal of property and equipment | (26) | (13) | 0 |
Changes in assets and liabilities: | |||
User funds | (15,307) | (29,729) | (42,039) |
Operating lease ROU assets and liabilities, net | (1,485) | 253 | 1,068 |
Other receivables | (4,847) | (6,240) | (1,777) |
Trade payables | (113) | 4,667 | (127) |
Deferred revenue | (792) | 4,123 | 2,680 |
User accounts | 14,416 | 26,589 | 39,014 |
Revaluation of contingent consideration | (12,249) | 11,771 | 398 |
Payment of contingent consideration | (504) | (507) | (1,960) |
Account payables, accrued expenses, and other non- current liabilities | 3,994 | 1,678 | 10,484 |
Net cash provided by operating activities | 30,112 | 38,037 | 17,135 |
Investing activities: | |||
Investment in marketable securities | (141,701) | (282,450) | (431,176) |
Proceeds from maturities of marketable securities | 130,701 | 193,757 | 183,190 |
Acquisition of business, net of cash acquired | 0 | (97,084) | 0 |
Bank and restricted deposits | 0 | (41,115) | (74,443) |
Acquisition of intangible asset, net | (175) | 0 | (1,230) |
Purchase of property and equipment | (1,198) | (1,684) | (2,094) |
Capitalization of internal-use software and other | (1,000) | (894) | (711) |
Other receivables and non-current assets | (1,251) | 0 | 107 |
Net cash used in investing activities | (14,624) | (229,470) | (326,357) |
Financing activities: | |||
Proceeds from follow-on offering, net | 0 | 0 | 129,853 |
Proceeds from issuance of convertible notes, net | 0 | (34) | 447,264 |
Purchase of capped call | 0 | 0 | (43,240) |
Proceeds from exercise of share options | 3,765 | 8,294 | 9,189 |
Payment of contingent consideration | (1,105) | (1,105) | (2,040) |
Tax withholding in connection with employees’ exercises of share options and vested RSUs | (2,028) | (8,987) | 11,311 |
Repayment of long-term loan | (2,269) | (565) | (524) |
Net cash provided by (used in) financing activities | (1,637) | (2,397) | 551,813 |
Effect of exchange rate fluctuations on cash and cash equivalents and restricted cash | (32) | (130) | 1,268 |
Increase (decrease) in cash, cash equivalents and restricted cash | 13,819 | (193,960) | 243,859 |
Cash, cash equivalents and restricted cash at the beginning of the year | 74,070 | 268,030 | 24,171 |
Cash, cash equivalents and restricted cash at the end of the year | 87,889 | 74,070 | 268,030 |
Supplemental non-cash disclosure: | |||
Purchase of property and equipment | 208 | 294 | 156 |
Share-based compensation capitalized in internal-use software | 274 | 247 | 40 |
Contingent consideration | 0 | 12,258 | 0 |
Lease liabilities arising from obtaining right-of-use assets | 359 | 229 | 19,031 |
Supplemental cash flow disclosure | |||
Cash paid for taxes | 235 | 78 | 0 |
Cash paid for interest | 246 | 107 | 115 |
Reconciliation of cash, cash equivalents and restricted cash | |||
Cash and cash equivalents | 86,752 | 71,151 | 268,030 |
Restricted cash | 1,137 | 2,919 | 0 |
Total cash, cash equivalents and restricted cash | $ 87,889 | $ 74,070 | $ 268,030 |
General
General | 12 Months Ended |
Dec. 31, 2022 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
General | Note 1: - General Fiverr International Ltd. was incorporated on April 29, 2010, under the laws of Israel, and commenced operations on the same date. Fiverr International Ltd. and its subsidiaries (the “Company”) operates a worldwide online marketplace for sellers to sell their services and buyers to buy them. The Company’s platform includes various categories across ten verticals, including Graphics & Design, Digital Marketing, Writing & Translation, Video & Animation, Music & Audio, Programming & Tech, Business, Data, Lifestyle and photography. The Company’s platform also includes a variety of value-added products including subscription-based content marketing platform, back-office platform, learning and development offerings, creative talent platform and freelancer management platform. Commencing June 13, 2019, the ordinary shares of the Company are traded on the New York Stock Exchange. |
Significant accounting policies
Significant accounting policies | 12 Months Ended |
Dec. 31, 2022 | |
Accounting Policies [Abstract] | |
Significant accounting policies | Note 2: - Significant accounting policies The consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the U.S. (“U.S. GAAP”). The significant accounting policies followed in the preparation of the consolidated financial statements, are as follows: a. Use of estimates: The preparation of consolidated financial statements, in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. The accounting estimates that require management’s subjective judgments include but are not limited to revenue recognition, income taxes, share-based compensation, purchase price allocation on acquisitions including determination of identifiable intangible assets of useful lives convertible notes borrowing rate, contingent consideration and impairment of intangible assets. The Company evaluates its estimates and judgments on an ongoing basis and revises them when necessary. Actual results may differ from the original or revised estimates. b. Principles of consolidation: The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. Intercompany transactions and balances were eliminated upon consolidation. c. Functional currency: The functional currency of the Company is the U.S. dollar, as it is the currency of the primary economic environment in which the Company is operating. Foreign currency transactions and balances have been re-measured to U.S. dollars in accordance with Accounting Standard Codification (“ASC”) Topic 830, “Foreign Currency Matters.” All transaction gains and losses from re- measurement of monetary balance sheet items denominated in foreign currencies are recorded under financial income (expenses), net. d. Cash and cash equivalents and restricted cash: The Company considers all investments with an original maturity of three months or less at the time of purchase to be cash equivalents including amounts related to payment processing companies. Restricted cash includes cash that is legally restricted as to withdrawal or usage. e. Marketable securities: The Company accounts for marketable securities in accordance with ASC Topic 320, “Investments – Debt and Equity Securities”. The Company’s investments in marketable securities consist of high-grade treasury, corporate and municipal bonds. Investments in marketable securities are classified as available for sale at the time of purchase. Available for sale securities are carried at fair value based on quoted market prices, with unrealized gains and losses, reported in accumulated other comprehensive income (loss) in shareholders’ equity. Realized gains and losses including interest and amortization of premium and discount arising from the acquisition of marketable securities were recorded under financial income (expenses), net. Following the adoption of ASC 326 the Company estimated expected credit losses for available for-sale debt securities in an unrealized loss position by considering a security’s probability of default and the recovery rate. The Company assessed the security’s credit indicators based on credit ratings. If the assessment indicates that an expected credit loss exists, the Company would determine the portion of the unrealized loss attributable to credit deterioration and would record an allowance for the expected credit loss. Unrealized gains and any portion of a security’s unrealized loss attributable to non-credit losses were recorded in other comprehensive income (loss). The Company has not recorded credit losses for the years ended December 31, 2022, 2021 and 2020. The Company classifies its marketable securities as either short term or long term based on each instrument’s underlying contractual maturity date as well as the intended time of realization. Marketable securities with maturities of 12 months or less are classified as short-term and marketable securities with maturities greater than 12 months are classified as long-term. On each reporting period the Company determines whether a decline in fair value below the amortized cost basis of an available for sale debt security is due to credit related factors or noncredit related factors. A credit related impairment would be recognized as an allowance on the balance sheet with a corresponding adjustment to earnings, however, if the Company would intend to sell an impaired available for sale debt security or more likely than not would be required to sell such a security before recovering its amortized cost basis, the entire impairment amount would be recognized in earnings with a corresponding adjustment to the security’s amortized cost basis. The Company did not recognize an allowance for credit losses on marketable securities as the expected losses were not material for the years ended December 31, 2022, 2021 and 2020. f. Bank deposits: Deposits with maturities of more than three months but less than one year are classified as short term. Such deposits are presented at their cost. g. Restricted deposit: Restricted deposit is restricted as to withdrawal or use. The Company maintains restricted deposits mainly for the lease of the Company’s office space. h. Long-lived assets: The Company’s long-lived assets to be held and used are comprised of property and equipment, identifiable intangible assets and Right-Of-Use (“ROU”) assets. Property and equipment is stated at cost, net of accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets. Computers and peripheral equipment is amortized at an annual rate of 33%, office furniture and equipment is amortized at annual rate ranges from 7%-15% and leasehold and improvements amortized over the shortest of the term of the lease or the useful life of the asset. Intangible assets that are considered to have definite useful life are amortized using the straight-line basis over their estimated useful lives, which ranges from 2 to 10 years. Long lived assets that are considered to have definite useful life are tested for impairment in accordance with ASC Topic 360, “Property, Plant and Equipment” whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The Company’s evaluation of recoverability is performed at the lowest level to which identifiable cash flows are largely independent of the cash flows of other assets and liabilities, and represent an asset group. Recoverability of this asset group is measured by a comparison of the aggregate undiscounted projections of future cash flows the asset group is expected to generate to the carrying amounts of the asset group. If such evaluation indicates that the carrying amount of the asset group is not recoverable, an impairment is measured by the amount which the carrying amount of the asset group exceeds their fair value. During the second quarter of 2022 due to an adverse change in macro-economic conditions the Company recorded an impairment of intangible assets in the amount of $27,629 mainly in connection with the asset group related to Stoke acquisition, asset group related to CreativeLive acquisition and internal use software capitalization. In determining the estimated fair value of the asset group, the Company utilized a discounted cash flow model. The key assumptions within the model related to forecasting of future revenue, appropriate discount rate and appropriate terminal value based on the nature of the asset group. No impairment was recorded for the years ended December 31, 2021 and 2020. i. Internal-use software: Costs incurred to develop internal-use software are capitalized and amortized over the estimated useful life of the software, which is generally three years. In accordance with ASC Topic, 350-40, “Internal-Use Software,” capitalization of costs to develop internal-use software begins when preliminary development efforts are successfully completed, the Company has committed project funding, it is probable that the project will be completed, and the software will be used as intended. Costs related to the design or maintenance of internal-use software are expensed as incurred. The Company periodically reviews internal-use software costs to determine whether the projects will be completed, placed in service, removed from service or replaced by other internally developed or third-party software. If the asset is not expected to provide any future benefit, the asset is retired, and any unamortized cost is expensed. Capitalized internal-use software costs are recorded under intangible assets. j. Business combinations: The results of an acquired business in a business combination are included in the Company’s consolidated financial statements from the date of acquisition according to the guidance of ASC Topic 805, “Business Combinations.” The Company allocates the purchase price, which is the sum of the consideration provided and may consist of cash, equity or a combination of the two, to the identifiable assets and liabilities of the acquired business at their fair values as of the acquisition date. The excess of the purchase price over the amount allocated to the identifiable assets and liabilities, if any, is recorded as goodwill. The estimated fair values and useful lives of identifiable intangible assets are based on many factors, including estimates and assumptions of future operating performance and cash flows of the acquired business, the nature of the business acquired and the specific characteristics of the identified intangible assets. The estimates and assumptions used to determine the fair values and useful lives of identified intangible assets could change due to numerous factors, including market conditions, technological developments, economic conditions and competition. Contingent consideration incurred in a business combination is included as part of the acquisition price and recorded at a probability weighted assessment of the fair value as of the acquisition date. The fair value of the contingent consideration is re-measured at each reporting period, with any adjustments in fair value recognized in earnings under general and administrative expenses. Acquisition related costs incurred by the Company are not included as a component of consideration transferred but are accounted for as an expense in the period in which the costs are incurred. k. Goodwill Goodwill represents the excess of the aggregate fair value of the consideration transferred in a business combination over the fair value of the assets acquired, net of liabilities assumed. Under ASC Topic 350, “Intangible—Goodwill and other,” goodwill is not amortized, but rather is subject to impairment test. ASC 350 allows an entity to first assess qualitative factors to determine whether it is necessary to perform a quantitative goodwill impairment test. If the qualitative assessment does not result in a more likely than not indication of impairment, no further impairment testing is required. If it does result in a more likely than not indication of impairment, a quantitative impairment test is performed. Alternatively, ASC 350 permits an entity to bypass the qualitative assessment for any reporting unit and proceed directly to performing the quantitative goodwill impairment test. The Company operates in one reporting segment, and this segment comprises its only reporting unit. The Company elected to perform an annual impairment test of goodwill as of October 1 st No goodwill impairment was recorded for the years ended December 31, 2022, 2021 and 2020. l. Derivatives and hedging: Derivatives are recognized at fair value as either assets or liabilities in the consolidated balance sheets in accordance with ASC Topic 815, “Derivatives and Hedging.” The gain or loss of derivatives which are designated and qualify as hedging instruments in a cash flow hedge, is recorded under accumulated other comprehensive income (loss) and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. The gain or loss in connection with forecasted transactions not probable of occurring was recorded under financial expenses, net. Derivatives are classified within Level 2 of the fair value hierarchy as the valuation inputs are based on quoted prices and market observable data of similar instruments. The Company entered into foreign currency cash flow hedges using forward, put and call option contracts to hedge certain forecasted payroll and other related payments denominated in NIS, to hedge against exchange rate fluctuations of the U.S. dollar. The Company recorded the cash flows associated with these derivatives under operating activities. m. Fair value of financial instruments: The Company measures and discloses the fair value of financial assets and liabilities in accordance with ASC Topic 820, “Fair Value Measurement.” Fair value is based on the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The accounting standard establishes a fair value hierarchy that prioritizes observable and unobservable inputs used to measure fair value into three broad levels, which are described below: Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs. Level 2: Observable inputs that are based on inputs not quoted on active markets but corroborated by market data. Level 3: Unobservable inputs are used when little or no market data is available. n. Concentrations of credit risks: Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, restricted cash, bank deposits, investment in marketable securities, restricted deposit and derivatives, which are placed in major banks in Israel, Germany and the U.S. User funds are held by a payment service provider which, pursuant to the agreement, was engaged to hold the user funds on behalf of buyers and sellers in an account segregated from the payment service provider’s operating bank account. The Company does not have off-balance sheet concentration of credit risks. o. Convertible notes: Prior to January 1, 2022 the Company accounts for convertible notes in accordance with ASC Topic 815, “Derivatives and Hedging” and ASC Topic 470, “Debt”. The Company separately accounted for debt and equity components of convertible notes that may be settled in cash. The carrying amount of the debt component was based on the fair value of a similar hypothetical debt instrument excluding the conversion option. The equity component was based on the excess of the principal amount of the convertible notes over the fair value of the debt component after adjustment for an allocation of issuance costs. The equity component is recorded under additional paid in capital and is not remeasured as long as it continues to meet the criteria for equity classification. The difference between the principal amount of the convertible notes and the amount allocated to the debt component was considered to be debt discount, which is subsequently amortized through interest expenses over the expected life of the convertible notes using the effective interest method. Issuance costs were allocated to the debt and equity components in proportion to the allocation of proceeds to those components. Commencing January 1, 2022 after the adoption of ASU 2020-06 the Company accounted for the convertible notes as a single liability and did not present the equity component separately. p. Employee related obligations: The Company accounts for employee related obligations in accordance with ASC Topic 715, “Compensation—retirement benefits.” The Israeli Severance Pay Law, 1963 (“Severance Pay Law”), specifies that employees are entitled to severance payment, following the termination of their employment. Under the Severance Pay Law, the severance payment is calculated as one-month salary for each year of employment, or a portion thereof. The Company’s liability for severance pay is covered by the provisions of Section 14 of the Severance Pay Law (“Section 14”). Under Section 14 employees are entitled to monthly deposits, at a rate of 8.33% of their monthly salary, contributed on their behalf to their insurance funds. Payments made in accordance with Section 14 release the Company from any future severance payments in respect of those employees. As a result, the Company does not recognize any asset or liability in connection with severance pay. Severance costs amounted to $4,567, $4,549 and $3,081 for the years ended December 31, 2022, 2021 and 2020, respectively. The Company’s U.S. Subsidiaries have a 401(K) defined contribution plan covering certain employees in the U.S. The expenses recorded by the U.S. subsidiaries for matching contributions for the years ended December 31, 2022, 2021 and 2020 were immaterial. q. User funds and user accounts: The Company has an arrangement with an existing payment service provider to hold funds on behalf of buyers and sellers (“users”). User funds consist of buyers’ prepayments, including the Company’s transaction and service fees that would be earned when an order is completed, credits issued upon cancellations and seller fees that have not yet been withdrawn. User accounts represent the corresponding liability to the users. The Company does not have ownership over the funds and does not have the right to direct the funds to be used at will or for its own benefit other than those funds related to transaction and service fees owed to the Company after control has been obtained by the customers. r. Leases: The Company determines if an arrangement meets the definition of a lease at the inception of the lease. ROU assets represent the right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease agreement. ROU asset is measured based on the discounted present value of the remaining lease payments, initial direct costs incurred and prepaid lease payments, excluding lease incentives. The lease liability is measured based on the discounted present value of the remaining lease payments. The discounted present value of remaining lease payments is computed using IBR based on the information available at the inception of the lease. The Company’s IBR was estimated to approximate the interest rate for collateralized borrowing with similar terms and payments and in economic environments where the leased asset was located. Lease term may include options to extend or terminate the lease when it is reasonably certain that the Company would exercise that option. The Company elected the practical expedient for lease agreements with a term of twelve months or less and does not recognized ROU assets and lease liabilities in respect of those agreements. Payments under the Company’s lease agreements are primarily fixed, however, certain lease agreements contain variable payments, which are expensed as incurred and not included in the operating lease ROU assets and liabilities. Variable lease payments are mainly comprised of payments affected by the consumer price index. The Company subleases certain office spaces to third parties. Sublease income is recognized over the term of the agreement. Lease expenses for lease payments are recognized on a straight-line basis over the lease term. The Company elected the practical expedient to not separate lease and non-lease components for its leases. s. Revenue: The Company’s revenue was primarily comprised of transaction fees and service fees. The Company earns transaction fees for enabling orders and providing other services and service fees to cover administrative fees. The Company’s customers are the users on its platform. Users accept the Company’s terms of service upon registration to the platform. Gross order amount including transaction and service fees is collected from the buyer upfront by a third-party payment provider. The prepaid amounts from buyers are simultaneously recorded as an asset under user funds with a corresponding liability to buyers under user accounts and deferred revenue until the order is completed or canceled. A contract with a customer exists only when: the parties to the contract have approved it and are committed to perform their respective obligations, the Company can identify each party’s rights regarding the distinct services to be transferred (“performance obligations”), the Company can determine the transaction price for the services to be transferred, the contract has commercial substance and it is probable that the Company will collect the consideration to which it will be entitled in exchange for the services that will be transferred to the customer. The Company’s revenues are primarily comprised of one distinct performance obligation which is to arrange services to be provided (including communication, engagement and payment processing) on its marketplace platform by the sellers to the buyers. The Company earns transaction fees and service fees that are based on the total value of transactions ordered through the platform once the buyer obtains control of the service, which occurs at a point in time upon completion of each order. Revenue is recorded in the amount of consideration to which the Company expects to be entitled in exchange for performance obligations upon transfer of control to the customer, excluding amounts collected on behalf of other third parties and indirect taxes. Revenue is mainly recognized on a net basis since the Company has concluded that it acts as an agent on its platform, mainly since it does not take responsibility for the sellers’ services and therefore it is not primary responsible for fulfilling the promise to provide the service and doesn’t have discretion in price establishment. Therefore, the Company does not obtain control of the services before they are transferred to the customer. The Company elected to use the practical expedient and recognize the incremental costs of obtaining contracts as an expense since the amortization period of the assets that the Company otherwise would have recognized is one year or less. Similarly, the Company does not disclose the value of unsatisfied performance obligations since the original expected duration of the contracts is one year or less. The Company recognizes revenue from unused user accounts balances once the likelihood of the users exercising their unused accounts balances becomes remote and the Company is not required to remit such unused account balances to a third party in accordance with applicable unclaimed property laws. The amounts recognized for the year ended December 31, 2022, 2021 and 2020 were immaterial. Revenue from subscriptions including the Company’s content marketing platform, on line learning platform, creative talent platform and back-office platform are mainly recognized over time when the service is rendered to the customer. Revenue from the Company’s freelancer management platform is recognized at a point time upon the management service is rendered. Disaggregated revenue: The Company’s transaction fees for the years ended December 31, 2022, 2021 and 2020 were $250,846, $217,086 and $139,019, respectively. The Company’s services fees for the years ended December 31, 2022, 2021 and 2020 were $86,520, $80,576 and $50,491, respectively. Contract liabilities: The Company’s contract liabilities mainly consist of deferred revenues from transaction and service fees received in advance for services for which control has not been yet obtained by the customers. Deferred revenues amounted to $11,353 and $12,145 as of December 31, 2022 and 2021, respectively. t. Cost of revenue: Cost of revenue is mainly comprised of expenses related to payment processing companies’ fees, server hosting fees, costs of the Company’s customer support personnel, amortization of capitalized internal-use software, developed technology and courses. u. Research and development expenses: Research and development expenses are primarily comprised of costs of the Company’s research and development personnel and other development related expenses. Research and development costs are expensed as incurred, except to the extent that such costs are associated with internal-use software that qualifies for capitalization. v. Sales and marketing expenses: Sales and marketing expenses are primarily comprised of costs of the Company’s marketing personnel, performance marketing investments, branding costs, amortization of customer relationships, creative relationships and trade name and other advertising costs. Sales and marketing expenses are expensed as incurred. Advertising costs were $119,519, $108,645 and $68,539 for the years ended December 31, 2022, 2021 and 2020, respectively. w. General and administrative expenses: General and administrative expenses primarily include costs of the Company’s executive, finance, legal and other administrative personnel, costs associated with fraud risk reduction and others. General and administrative expenses are expensed as incurred. x. Share based compensation: The Company accounts for share-based compensation in accordance with ASC Topic 718, “Compensation—Stock Compensation.” Share based awards are mainly granted to employees and members of the Company’s board of directors and measured at fair value at each grant date. The Company calculates the fair value of share options and Employee Share Purchase Plans (“ESPP”) on the date of grant using the Black-Scholes option-pricing model and the expense is recognized over the requisite service period for awards expected to vest using the straight line method. The Company recognizes the fair value of Restricted Share Units (“RSUs”) on the grant date based on the market value of the underlying share and the expense is recognized over the requisite service period for awards using the straight line method. The requisite service period for share options is generally four years. The Company recognizes forfeitures as they occur. The Black-Scholes option-pricing model requires the Company to make a number of assumptions including the fair value of our ordinary shares, expected volatility, expected term, risk-free interest rate and expected dividends. The Company evaluates the assumptions used to value share options and ESPP upon each grant date. Expected volatility of share options was calculated based on the Company’s volatility as well as the implied volatilities from market comparisons of certain publicly traded companies and other factors. Expected volatility for ESPP was calculated based upon the Company’s share prices. The expected share options term was calculated based on the simplified method, which uses the midpoint between the vesting date and the contractual term, as the Company does not have sufficient historical data to develop an estimate based on participant behavior. The risk-free interest rate was based on the U.S. treasury bonds yield with an equivalent term. The Company has not paid dividends and has no foreseeable plans to pay dividends. y. Income taxes: The Company accounts for income taxes in accordance with ASC Topic 740, “Accounting for Income Taxes,” using the liability method. Under the liability method, deferred assets and liabilities are recognized based upon anticipated future tax consequences attributable to differences between the financial statement carrying amounts of assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using the enacted tax rates that will be in effect for the years in which those tax assets are expected to be realized or settled. The Company regularly assesses the likelihood that its deferred tax assets will be realized from recoverable income taxes or recovered from future taxable income based on the realization criteria set forth in the relevant authoritative guidance. To the extent the Company believes any amounts are not more likely than not to be realized, the Company records a valuation allowance to reduce its deferred tax assets. The realization of deferred tax assets is dependent upon future earnings, if any, the timing and amount of which are uncertain. Accordingly, the net deferred tax assets have been fully offset by a valuation allowance. If the Company subsequently realizes or determines it is more likely than not that it will realize deferred tax assets that were previously determined to be unrealizable, the respective valuation allowance would be reversed, resulting in an adjustment to earnings in the period such determination is made. The Company recognizes uncertain tax positions based on its estimate of whether, and the extent to which, additional taxes will be due. These liabilities are established utilizing a two-step approach when the Company believes that certain positions might be challenged despite its belief that its tax return positions are fully supportable. The first step requires the Company to determine if the weight of available evidence indicates a tax position is more likely than not to be sustained upon audit. The second step is based on the largest amount of benefit, which is more likely than not to be realized on ultimate settlement. Any interest and penalties related to unrecognized tax benefits are recorded as income tax expense. The Company adjusts these liabilities in light of changing facts and circumstances, such as the outcome of a tax audit or changes in the tax law. z. Segment reporting: The Company identifies operating segments in accordance with ASC Topic 280, “Segment Reporting” as components of an entity for which discrete financial information is available and is regularly reviewed by the chief operating decision maker, or decision-making group, in making decisions regarding resource allocation and evaluating financial performance. The Company defines the term “chief operating decision maker” to be its chief executive officer. The Company determined it operates in one operating segment and one reportable segment, as its chief operating decision maker reviews financial information presented only on a consolidated basis for purposes of allocating resources and evaluating financial performance. aa. Loss per share: The Company computes basic loss per share in accordance with ASC Topic 260, “Earnings per Share” by dividing the net loss attributable to ordinary shareholders by the weighted average number of ordinary shares outstanding during the year. Diluted loss per share is computed by taking into account the potential dilution that could occur upon the exercise of share options and ESPP and vesting of RSUs granted under share based compensation plans using the treasury stock method and the potential dilution that could occur upon conversion of the convertible notes using the if converted method. The potentially dilutive unvested RSUs, share options to purchase ordinary shares and potentially dilutive ordinary shares from conversion of convertible notes that were excluded from the computation amounted to 6,386,203 ab. Contingencies: The Company accrues for loss contingencies when losses become probable and are reasonably estimable. If the reasonable estimate of the loss is a range and no amount within the range is a better estimate, the minimum amount of the range is recorded as a liability. The Company does not accrue for contingent losses that, in its judgment, are considered to be reasonably possible, but not probable; however, it discloses the range of such reasonably possible losses. ac. Recently adopted accounting pronouncements: In October 2021 the FASB ASU 2021-08, Topic 805 “Business Combinations” – Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. The amendments in this update require that an entity (acquirer) recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606. At the acquisition date, an acquirer should account for the related revenue contracts in accordance with Topic 606 as if it had originated the contracts. To achieve this, an acquirer may assess how the acquiree applied Topic 606 to determine what to record for the acquired revenue contracts. The amendments |
Certain transactions
Certain transactions | 12 Months Ended |
Dec. 31, 2022 | |
Business Combinations [Abstract] | |
Certain transactions | Note 3: - Certain transactions a. Working Not Working acquisition: In January 2021, the Company acquired all the outstanding shares of Working Not Working, Inc. (“WnW”), a creative talent platform for a consideration of $9,922. The results of operations of WnW were consolidated in the Company’s financial statements commencing the date of acquisition. The agreement stipulated additional contingent payments which are not included in the total consideration to the shareholders of WnW in an aggregate amount of up to $3,500 subject to the continuing employment, out of which the Company recorded a liability of $1,500 as of December 31, 2021 which was fully paid during 2022. T : Fair value Amortization period Cash and cash equivalents $ 910 Other tangible assets assumed 369 Creative relationships 4,252 10 years Customer relationships 812 2 years Trade name 362 3 years Goodwill 4,525 Total assets acquired 11,230 Total liabilities (1,308 ) Net assets acquired $ 9,922 The Company incurred approximately $292 in acquisition expenses for the year ended December 31, 2021 recorded under general and administrative expenses. Pro forma results of operations related to this acquisition have not been presented because they are not material to the Company’s consolidated statements of operations. b. CreativeLive acquisition: In October 2021, the Company acquired all of the outstanding shares of CreativeLive, Inc. (“CreativeLive”), an online learning platform for a consideration of $9,332. The results of operations of CreativeLive were consolidated in the Company’s financial statements commencing the date of acquisition. The agreement stipulated additional payments which were not included in the consideration including a to employees of CreativeLive by shareholders for past services in the amount of $1,500 paid at closing and retention bonus of $1,500 subject to continuing employment, out of which the Company recorded $1,125 and $375 under operating expenses for the years ended December 31, 2022 and 2021. The outstanding liability was fully paid d uring 2022. The agreement also stipulated contingent payments to shareholders of CreativeLive in an aggregate amount of up to $1,500 subject to certain milestones to be paid after 18 months. The table below summarizes the preliminary fair value of the acquired assets and assumed liabilities and the goodwill as of the acquisition date: Fair value Amortization period Cash and cash equivalents $ 2,066 Other tangible assets assumed 552 Courses 1,311 2 years Customer relationships 1,447 2 years Technology 1,522 4 years Trade name 557 5 years Goodwill 5,139 Total assets acquired 12,594 Deferred revenue and other liabilities assumed (3,262 ) Net assets acquired $ 9,332 The Company incurred approximately $121 in acquisition expenses for the year ended December 31, 2021 recorded under general and administrative expenses. Pro forma results of operations related to this acquisition have not been presented because they are not material to the Company’s consolidated statements of operations. c. Stoke Talent acquisition I . The results of operations of Stoke were consolidated in the Company’s financial statements commencing the date of acquisition. The agreement stipulated additional contingent payments to shareholders of Stoke in an aggregate amount of up to $15,000 subject to certain milestones to be paid after one year. The fair-value of the contingent consideration as of the acquisition date was $12,258 and measured based on the estimated future cash outflows, utilizing the Monte Carlo simulation. As of December 31, 2021 the liability was recorded under other non-current liabilities. During 2022 the Company reversed the liability since the corresponding milestones were not met . T : Cash paid $ 93,084 Fair value of contingent consideration 12,258 Fair value of unvested options 313 Total fair value of consideration transferred $ 105,655 The table below summarizes the fair value of the acquired assets and assumed liabilities and the resulting goodwill as of the acquisition date: Fair value Amortization period Cash and cash equivalents $ 12,278 Other tangible assets assumed 1,160 Developed technology 35,691 7 years Customer relationships 506 5 years Trade name 752 6 years Goodwill 56,367 Total assets acquired 106,754 Total liabilities assumed (1,099 ) Net assets acquired $ 105,655 The Company incurred approximately $97 in acquisition expenses for the year ended December 31, 2021 recorded under general and administrative expenses. Pro forma results of operations related to this acquisition have not been presented because they are not material to the Company’s consolidated statements of operations. |
Fair value of financial instrum
Fair value of financial instruments | 12 Months Ended |
Dec. 31, 2022 | |
Fair Value Disclosures [Abstract] | |
Fair value of financial instruments | Note 4: - Fair value of financial instruments The following tables set forth the fair value of the Company’s financial assets and liabilities measured at fair value as of: December 31, 2022 Level 1 Level 2 Level 3 Cash and cash equivalents: Cash $ 52,558 $ - $ - Restricted cash 1,137 - - Money market funds 30,828 - - Bank deposits 3,366 - - Bank deposits 134,000 - - Restricted deposits 50 - - Marketable securities - 431,132 - Asset derivatives - 60 - Liability derivatives - (1,444 ) - $ 221,939 $ 429,748 $ - December 31, 2021 Level 1 Level 2 Level 3 Cash and cash equivalents: Cash $ 48,264 $ - $ - Restricted cash 2,919 - - Money market funds 19,091 - - Bank deposits 3,796 - - Bank deposits 134,000 - - Restricted deposits 50 - - Marketable securities - 435,674 - Asset derivatives - 822 - Liability derivatives - (4 ) - Contingent consideration - - (13,858 ) $ 208,120 $ 436,492 $ (13,858 ) The following table sets forth a summary of the changes in the fair value of the contingent consideration: Fair value as of December 31, 2021 $ (13,858 ) Payment 1,609 Revaluation 12,249 Fair value as of December 31, 2022 $ - The fair value of other financial instruments included in working capital and other non-current assets and liabilities approximate their carrying value. As of December 31, 2022, the total estimated fair value of the convertible notes was approximately $373,428. The fair value of the convertible notes is considered to be Level 2 within the fair value hierarchy and was determined based on the quoted price of the convertible notes in an over-the-counter market. |
Marketable securities
Marketable securities | 12 Months Ended |
Dec. 31, 2022 | |
Investments, Debt and Equity Securities [Abstract] | |
Marketable securities | Note 5: - Marketable securities As of December 31, 2022, the amortized cost, unrealized holding gains and losses and fair value of marketable securities were as follows: Amortized Unrealized Unrealized Cost gains losses Fair Value Municipal and U.S. treasury bonds $ 77,005 $ 2 $ (2,559 ) $ 74,448 Corporate bonds 364,904 7 (8,227 ) 356,684 Total $ 441,909 $ 9 $ (10,786 ) $ 431,132 As of December 31, 2021, the amortized cost, unrealized holding gains and losses and fair value of marketable securities were as follows: Amortized Unrealized Unrealized Cost gains losses Fair Value Municipal and U.S. treasury bonds $ 47,325 $ 2 $ (237 ) $ 47,090 Corporate bonds 390,261 33 (1,710 ) 388,584 Total $ 437,586 $ 35 $ (1,947 ) $ 435,674 The following table summarizes the fair value and amortized cost of the available-for-sale securities by contractual maturity as of December 31, 2022: Amortized Fair Value Due within one year $ 245,615 $ 241,293 Due after one year through two years 196,294 189,839 Total $ 441,909 $ 431,132 |
Property and equipment, net
Property and equipment, net | 12 Months Ended |
Dec. 31, 2022 | |
Property, Plant and Equipment [Abstract] | |
Property and equipment, net | Note 6: - Property and equipment, net Property and equipment, net consisted of the following as of: December 31, 2022 2021 Leasehold improvements $ 6,271 $ 6,182 Computers and peripheral equipment 5,431 4,513 Office furniture and equipment 1,563 1,570 13,265 12,265 Less—accumulated depreciation (7,605 ) (5,710 ) $ 5,660 $ 6,555 Depreciation expenses were $2,032, $1,739 and $1,207 for the years ended December 31, 2022, 2021 and 2020, respectively. |
Intangible assets, net
Intangible assets, net | 12 Months Ended |
Dec. 31, 2022 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Intangible assets, net | Note 7: - Intangible assets, net The gross carrying amount of intangible assets net of impairment, net consisted of the following as of: December 31, 2022 2021 Developed technology $ 15,778 $ 41,133 Capitalized internal-use software 5,842 5,857 Customer relationships 4,335 5,425 Creative relationships 4,252 4,252 Trade name 2,035 2,841 Courses 890 1,312 Workforce 1,250 1,250 34,382 62,070 Less: Accumulated amortization and impairment ( 19,612 ) (12,849 ) Net carrying amount $ 14,770 $ 49,221 In connection with internal-use software, the Company capitalized $ 953 , $1,261 and $577 for the years ended December 31, 2022, 2021 and 2020, respectively. The capitalized amount included share-based compensation of $ , $247 and $40 for the years ended December 31, 2022, 2021 and 2020, respectively. Amortization expenses amounted to $ 8,153 , $5,137 and $3,131 for the years ended December 31, 2022, 2021 and 2020, respectively. During 2022 CreativeLive acquired additional courses in the amount of $175. The estimated future amortization of intangible assets as of December 31, 2022 was as follows: 2023 $ 4,168 2024 2,323 2025 2,040 2026 1,908 2027 and thereafter 4,331 $ 14,770 |
Derivatives and hedging
Derivatives and hedging | 12 Months Ended |
Dec. 31, 2022 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Derivatives and hedging | Note 8: - Derivatives and hedging The Company had outstanding contracts designated as hedging instruments in the aggregate notional amount of $ 64,000 and $49,620 as of December 31, 2022 and 2021, respectively. The fair value of the Company’s outstanding contracts amounted to an asset of $ and a liability of $ as of December 31, 2022 and an asset of $ and a liability of $ as of December 31, 2021. These assets and liabilities were recorded under other receivables and other account payables and accrued expenses respectively. A loss of $4,082 and gains of $1,160, and $1,267 were reclassified from accumulated other comprehensive loss during the years ended December 31, 2022, 2021 and 2020, respectively. Such gains and losses were reclassified from accumulated other comprehensive loss when the related expenses were incurred. These gains and losses were recorded in the consolidated statements of operations were as follows for the years ended: December 31, 2022 2021 2020 Cost of revenue $ 123 $ (35 ) $ (87 ) Research and development 2,640 (717 ) (655 ) Sales and marketing 1,025 (266 ) (311 ) General and administrative 294 (142 ) (214 ) $ 4,082 $ (1,160 ) $ (1,267 ) In addition, losses of $875 were reclassified from other comprehensive loss to financial expenses, net in connection with forecasted transactions not probable of occurring. |
Other account payables and accr
Other account payables and accrued expenses | 12 Months Ended |
Dec. 31, 2022 | |
Payables and Accruals [Abstract] | |
Other account payables and accrued expenses | Note 9: - Other account payables and accrued expenses Other account payables and accrued expenses consisted of the following as of: December 31, 2022 2021 Accrued expenses and other $ 24,859 $ 23,659 Accrued payroll and government authorities 14,705 16,649 Tax withholding in connection with employees’ exercises of share options and vested RSUs 320 2,348 Contingent consideration - 1,600 Derivatives 1,444 4 $ 41,328 $ 44,260 |
Leases
Leases | 12 Months Ended |
Dec. 31, 2022 | |
Leases [Abstract] | |
Leases | Note 10: - Leases The Company leases office spaces under non-cancellable operating lease agreements in Israel and the U.S. that expire through October 2026. The Company subleases a portion of its Israel office space. The components of operating lease cost recorded under operating expenses for the year ended December 31, 2022 and 2021 were as follows: December 31, 2022 2021 2020 Fixed cost and variable cost that depend on an index $ 3,312 $ 3,258 3,192 Short term lease cost 23 136 277 Sublease income (434 ) (705 ) (792 ) $ 2,901 $ 2,689 2,677 Weighted average remaining lease term as of December 31, 2022 3.84 years Weighted average discount rate 2.3 % The minimum lease payments for the Company’s ROU assets over the remaining lease periods as of December 31, 2022, were as follows: 2023 $ 2,723 2024 2,275 2025 2,275 2026 2,275 2027 and after - Total undiscounted lease payments 9,548 Less: imputed interest (144 ) Present value of lease liabilities $ 9,404 |
Commitments and contingencies
Commitments and contingencies | 12 Months Ended |
Dec. 31, 2022 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and contingencies | Note 11: - Commitments and contingencies From time to time, the Company may be involved in various claims and legal proceedings. The Company reviews the status of each matter and assesses its potential financial exposure. If the potential loss from any claim or legal proceeding is considered probable and the amount can be reasonably estimated the Company would accrue a liability for the estimated loss. As of December 31, 2022 and 2021, the Company is not involved in any material claims or legal proceedings which require accrual of liability for the estimated loss. |
Convertible notes
Convertible notes | 12 Months Ended |
Dec. 31, 2022 | |
Debt Disclosure [Abstract] | |
Convertible notes | Note 12: - Convertible notes a. Convertible notes In October 2020, the Company issued $460,000 aggregate principal amount, 0% coupon rate of convertible notes due on 2025 (inclusive of an additional $60,000 aggregate principal amount of such notes pursuant to the exercise in full of the overallotment option of the initial purchasers). The convertible notes are convertible based upon an initial conversion rate of 4.6823 of the Company’s ordinary shares, per share per $1 principal amount of convertible notes (equivalent to a conversion price of approximately $213.57 per ordinary share). The conversion rate is subject to adjustment upon the occurrence of certain specified events. The convertible notes are senior unsecured obligations of the Company. The convertible notes mature on November 1, 2025, unless earlier repurchased, redeemed or converted. Prior t o May 15, 2025, a holder may convert all or a portion of its convertible notes only under the following circumstances: (i) during any calendar quarter commencing after the calendar quarter ending on December 31, 2020 (and only during such calendar quarter), if the last reported sale price of the Company’s ordinary shares for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day; (ii) during the five business day period after any 10 consecutive trading day period in which the trading price, determined pursuant to the terms of the convertible notes, per $1 principal amount of convertible notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of the ordinary shares and the conversion rate on each such trading day; (iii) if the Company calls such convertible notes for redemption in certain circumstances, at any time prior to the close of business on the third scheduled trading day immediately preceding the redemption date; or (iv) upon the occurrence of specified corporate events. On or after May 15, 2025 until the close of business on the third scheduled trading day immediately preceding the maturity date, a holder may convert its convertible notes at any time, regardless of the foregoing circumstances. Upon conversion, the Company can pay or deliver cash, ordinary shares or a combination of cash and ordinary shares, at the Company’s election. The Company may not redeem the convertible notes prior to November 5, 2023, except in the event of certain tax law changes. The Company may, at any time and from time to time, redeem for cash all or any portion of the convertible notes, at the Company’s option, on or after November 5, 2023, if the last reported sale price of the Company`s ordinary shares has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which it delivers notice of redemption at a redemption price equal to 100% of the principal amount of the convertible notes to be redeemed. Upon the occurrence of a fundamental change as defined in the indenture, holders may require the Company to repurchase for cash all or any portion of their convertible notes at a fundamental change repurchase price equal to 100% of the principal amount of the convertible notes to be repurchased (plus accrued and unpaid special interest payable under certain circumstances set forth in the terms of the convertible notes (if any) to, but excluding, the fundamental change repurchase date. In addition, in connection with a make-whole fundamental change as defined in the indenture or following the Company’s delivery of a notice of redemption, the company will, in certain circumstances, increase the conversion rate for a holder who elects to convert its convertible notes in connection with such a corporate event or redemption, as the case may be. Issuance costs attributable to the debt and equity components prior to the adoption of ASU 2020-06 were $ 9,969 and $2,842, respectively. The effective borrowing rate of the debt component of the convertible notes was 5.1%. This borrowing rate was based on the Company’s synthetic credit risk rating determined by a third-party appraiser. The annual effective interest rate of the debt component following the adoption of ASU 2020-06 was 0.56%. During and as of the year ended December 31, 2022, the conditions allowing holders of the convertible senior notes to convert were not met therefore the notes were classified as long-term liability. The net carrying amount of convertible notes as of December 31, 2022 and 2021 were as follows: December 31, Debt component: 2022 2021 Principal amounts $ 460,000 $ 460,000 Unamortized discount - 85,478 Unamortized issuance costs 7,236 2,446 Net carrying amount $ 452,764 $ 372,076 Equity component, net $ - $ 99,190 Financial expenses related to the convertible senior notes for the year ended December 31, 2022 and 2021 were as follows: December 31, 2022 2021 2020 Amortization of discount $ - $ 19,473 3,677 Amortization of issuance costs 2,527 556 359 $ 2,527 $ 20,029 4,036 b. Capped call In connection with the pricing of the convertible notes and the exercise of the overallotment option, the Company entered into privately negotiated capped call transactions with certain financial institutions. The capped call transactions cover, collectively, the number of the Company’s ordinary shares underlying the convertible notes, subject to anti-dilution adjustments substantially similar to those applicable to the convertible notes. The capped call has an initial strike price of $213.57 per ordinary share, subject to certain adjustments, which corresponds to the approximate initial conversion price of the convertible notes. The cap price of the capped call is initially $305.1 per ordinary share and is subject to certain adjustments under the terms of the capped call. The capped call transactions were considered to be freestanding instruments as they were entered into separately and apart from the convertible notes and since the conversion or redemption of the convertible notes does not automatically result in the exercise of the capped call. The capped call transactions are indexed to the Company’s own shares and meet the criteria for equity classification. The cost of the capped call transactions was approximately $43,240 recorded as a reduction to additional paid in capital with no subsequent measurement. |
Long term loan and other non-cu
Long term loan and other non-current liabilities | 12 Months Ended |
Dec. 31, 2022 | |
Debt Disclosure [Abstract] | |
Long term loan and other non-current liabilities | Note 13: - Long term loan and other non-current liabilities Long-term loan and other long-term liabilities consisted of the following as of: December 31, 2022 2021 Contingent consideration $ - $ 12,258 Other 1,559 841 $ 1,559 $ 13,099 |
Shareholders' equity
Shareholders' equity | 12 Months Ended |
Dec. 31, 2022 | |
Stockholders' Equity Note [Abstract] | |
Shareholders' equity | Note 14: - Shareholders’ equity a. On June 2, 2020 the Company closed a follow on offering whereby b. Holders of ordinary shares are entitled to c. Share options and RSUs: In 2011, the board of directors adopted the 2011 share option plan for employees, officers, directors and consultants (the “2011 Plan”). Each share option granted under the 2011 Plan expires no later than ten years from the date of grant. The vesting period of the share options is generally four years. As of December 31, 2019, the Company is no longer granting any awards under the 2011 Plan. In 2019, the board of directors adopted the 2019 share incentive plan (the “2019 Plan”) for employees, officers, directors and consultants. The 2019 Plan provides for the grant of share options (including incentive share options and non-qualified share options), ordinary shares, restricted shares, RSUs and other share-based awards. Each share option granted under the 2019 Plan expires no later than seven years from the date of grant. The vesting period of the share options is generally four years. As of December 31, 2022 the total of ordinary shares available for future grants under the 2019 Plan was 3,551,789. The following table summarizes the status of the share options as of and for the year ended: December 31, 2022 Number of Weighted- Weighted- contractual Outstanding at the beginning of the year 2,908,598 $ 47.85 6.04 Granted 560,060 61.91 Exercised (282,479 ) 12.99 Forfeited (89,965 ) 83.29 Outstanding at the end of the year 3,096,214 52.54 5.27 Exercisable at the end of the year 2,176,521 $ 32.85 5.07 The fair value of these share options was estimated on the grant date based on the following weighted average assumptions for the years ended: December 31, 2022 2021 2020 Volatility 54 57 50% – 55 46% – 50 Expected term in years 3.78 4.56 3.67 – 4.61 4.42 – 4.56 Risk-free interest rate 1.87% – 4.4% 0.43 1.11 0.2% – 1.41% Estimated fair value of underlying ordinary shares 27.55 – 81.03 170.35 – 323.10 27.90 – 158.89 Dividend yield 0% 0% 0% The share options outstanding under the 2011 plan as of December 31, 2022, have been separated into exercise price groups as follows: Outstanding Exercisable Exercise price Number of Weighted Number of Weighted $0.00-$1.87 322,911 3.84 322,911 3.84 $1.88-$5.55 416,552 5.06 416,552 5.06 $5.56-$12.78 675,724 5.96 621,545 5.95 $12.79 -$23.08 179,960 6.12 167,805 6.14 $23.04-$25.82 381,891 3.83 305,925 3.80 $25.83-$35.35 262,031 6.60 15,883 6.30 $35.36-$81.03 246,299 4.82 132,684 4.76 $81.04-$186.75 248,276 5.98 51,884 5.98 $186.76-$236.86 220,496 5.59 73,687 5.58 $236.87-$323.10 142,074 5.13 67,645 5.13 Total 3,096,214 5.27 2,176,521 5.07 Aggregate intrinsic value $ 32,976 $ 31,722 Intrinsic value represents the potential amount receivable by the option holders had all option holders exercised their share options as of such date. The aggregate intrinsic value of the exercised share options was $10,873, $142,419 and $128,463 for the years ended December 31, 2022, 2021 and 2020, respectively. The grant-date fair value of vested share options was $23,346, $25,536 and $12,620 for the years ended December 31, 2022, 2021 and 2020, respectively. The following table summarizes the status of RSUs as of and for the year ended: December 31, 2022 Number of Weighted- Outstanding at the beginning of the year 778,160 169.07 Granted 1,055,447 64.08 Vested (380,062 ) 132.55 Forfeited (317,417 ) 123.43 Outstanding at the end of the year 1,136,128 96.49 h. Employee Share Purchase Plan: In August 2020, the Company adopted the 2020 Employee Share Purchase Plan (the “ESPP”). As of December 31, 2022, a total of 701,205 shares were reserved for issuance under the ESPP. In addition, on the first day of each calendar year beginning on January 1, 2022 and ending on and including January 1, 2030, the number of shares available for issuance under the ESPP will be increased by the lesser of 1% of the shares outstanding on the final day of the immediately preceding calendar year, as determined on a fully diluted basis, and such smaller number of shares as determined by the Company’s board of directors. According to the ESPP, eligible employees may use up to 15% of their salaries to purchase ordinary shares. The price of an ordinary share purchased under the ESPP is equal to 85% of the lower of the fair market value of the ordinary share on the beginning of each offering period or on the purchase date. As of December 31, 202 , ordinary shares had been issued under the ESPP. The ESPP is compensatory and, as such, results in recognition of compensation cost. The fair value of ESPP was estimated on the grant date based on the following weighted average assumptions for the years ended: December 31, 2022 2021 2020 Volatility 86.4-97.6 % 86.0-86.4 % 61.9 Expected term in years 0.5 0.5 0.5 Risk-free interest rate 0.08-4.24 % 0.03-0.08 % 0.09 Estimated fair value of underlying ordinary shares 35.36-206.07 131.88-206.07 196.89 Dividend yield 0 % 0 % 0% Share-based compensation costs are recorded in the consolidated statements of operations for the years ended: December 31, 2022 2021 2020 Cost of revenue $ 2,520 $ 1,436 $ 384 Research and development 23,828 20,008 5,842 Sales and marketing 17,196 14,106 3,084 General and administrative 28,211 19,857 6,505 $ 71,755 $ 55,407 $ 15,815 The total unrecognized share-based compensation cost as of December 31, 2022 was $144,610, which will be recognized over a weighted-average period of 2.55 years. |
Financial income (expenses), ne
Financial income (expenses), net | 12 Months Ended |
Dec. 31, 2022 | |
Component Of Other Non Operating Income Expense [Abstract] | |
Financial income (expenses), net | Note 15: - Financial income (expenses), net Year ended December 31, 2022 2021 2020 Bank charges and other financial expenses $ (596 ) $ (134 ) $ (369 ) Amortization of discount and issuance costs of convertible notes (2,527 ) (20,029 ) (4,036 ) Derivatives and hedging (875 ) - - Exchange rate gain (loss), net 1,141 (1,273 ) (262 ) Interest income 6,481 1,923 1,867 $ 3,624 $ (19,513 ) $ (2,800 ) |
Income taxes
Income taxes | 12 Months Ended |
Dec. 31, 2022 | |
Income Tax Disclosure [Abstract] | |
Income taxes | Note 16: - Income taxes Fiver International Ltd.’s subsidiaries are separately taxed under the domestic tax laws of the jurisdiction of incorporation of each entity. a. Loss before income taxes: The following are the domestic and foreign components of the Company’s loss before income taxes for the years ended: December 31, 2022 2021 2020 Domestic $ (62,905 ) $ (58,166 ) $ (11,097 ) Foreign (8,005 ) (6,687 ) (3,513 ) $ (70,910 ) $ (64,853 ) $ (14,610 ) b. Income taxes: The following are the domestic and foreign components of the Company’s income taxes for the years ended: December 31, 2022 2021 2020 Domestic $ 632 $ - $ - Foreign (55 ) 159 200 $ 577 $ 159 $ 200 c. Deferred income taxes: Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The principal components of the Company’s deferred tax assets are as follows for the years ended: December 31, 2022 2021 Deferred tax assets: Net operating loss carryforwards $ 38,850 $ 44,480 Research and development expenses carryforward 3,989 2,262 A 7,369 1,630 Share-based compensation 12,674 7,584 Operating lease liabilities 2,173 1,033 Issuance costs - 630 Total deferred tax asset $ 65,055 $ 57,619 Deferred tax liabilities: Operating lease ROU assets 2,097 998 Convertible notes 102 17,275 Acquired Intangible assets 1,060 2,253 Accrued and other 17 603 Total deferred tax liability $ 3,276 $ 21,129 Total deferred tax assets, net 61,779 36,490 Less—valuation allowance (61,779 ) (36,490 ) Total deferred tax assets, net of valuation allowance $ - $ - Based on the available evidence, management believes that it is more likely than not that certain of its deferred tax assets relating to net operating loss carryforwards and other temporary differences will not be realized and accordingly, a valuation allowance has been provided. d. The reconciliation of the Company’s theoretical income tax expense to actual income tax expense is as follows: Year ended December 31, 2022 2021 2020 Loss before income taxes $ (70,910 ) $ (64,853 ) $ (14,610 ) Statutory tax rate 23 % 23 % 23 % Theoretical tax benefit 16,309 14,916 3,360 Increase (decrease) in effective tax rate due to: Change in valuation allowance (4,491 ) (4,474 ) (2,558 ) Effect of entities with different tax rates (145 ) (28 ) (47) Non-deductible expenses (12,433 ) (11,501 ) (2,964 ) Impact of different tax rate on temporary differences - (462 ) (119 ) Excess tax benefit on stock based compensation 593 1,562 2,178 Uncertain tax provision (302 ) - - Other (108 ) (172 ) (50 ) Effective income taxes $ (577 ) $ (159 ) $ (200 ) e. Net operating loss carryforward: As of December 31, 2022, the Company had an indefinite Net Operating Losses (“NOL”) carryforward for Israeli tax purposes of approximately $96,864. This NOL carryforward can be carried forward and offset against taxable income. The Company also had a NOL carryforward for U.S. tax purposes of approximately $75,695 as of December 31, 2022. NOL’s for U.S. Federal income tax purposes (“Federal NOL’s”) generated in the years ended December 31, 2014 through 2017 will begin to expire in 2035 for federal income tax purposes. Federal NOL’s originating before January 1, 2018, are eligible to offset taxable income, if not otherwise limited under Internal Revenue Code (“IRC”) 382 limitations. Federal NOL’s generated after December 31, 2017, have an infinite carryforward period and are subject to 80% deduction limitation based upon pre-NOL deduction taxable income. All of the federal NOL’s of the Company are expected to be subject to certain limitations under 382 following that change in control that occurred upon acquisition of ClearVoice, Working Not Working, Inc. and CreativeLive. f. Basis of taxation: The Israeli corporate tax rate was 23% for the years ended December 31, 2022, 2021 and 2020. The Company has elected 2012 to be its election year to be eligible for “Beneficiary Enterprise” standing under amendment No. 60 to tax benefits section No. 51 to the Law for the Encouragement of Capital Investments, 1959 (the “Law”). Pursuant to the provisions of the Law, in the event that the Company is profitable for tax purposes, the Company’s undistributed income will be tax- exempt for a period of two years beginning from the year in which taxable income is first earned. In the remaining years of benefits (between three to eight years, depending on the level of non-Israeli investments), the Company will be liable to reduced corporate tax at the rate of 10% to 25%, based on the percentage of foreign ownership. Any income derived from sources other than from the Beneficiary Enterprise would be subject to the statutory corporate tax rate. The period of tax benefits described above is subject to limits of 12 years from the year of election. The entitlement to the above benefits is conditional upon the Company’s fulfilling the conditions stipulated by the Law, regulations published there under and the letters of approval for the specific investments in “Beneficiary Enterprise.” In the event of failure to comply with these conditions, the benefits may be cancelled, and the Company may be required to refund the amount of the benefits, in whole or in part, including interest. In December 2016, the Economic Efficiency Law (Legislative Amendments for Applying the Economic Policy for the 2017 and 2018 Budget Years), published Amendment No. 73 to the Law for the Encouragement of Capital Investments (the “2017 Amendment”) which reduces the corporate income tax rate to 24% (instead of 25%) effective from January 1, 2017 and to 23% effective from January 1, 2018. In addition, according to the 2017 Amendment, a preferred enterprise located in development area A will be subject to a tax rate of 7.5% instead of 9% effective from January 1, 2017 and thereafter (the tax rate applicable to preferred enterprises located in other areas remains at 16%). In December 2016, pursuant to amendment No. 73 to the law, the tax rate on preferred Technological Enterprise income was reduced to 12%. This amendment became effective in January 2017. The Company is currently evaluating the scope of the amendment. On December 22, 2017, the Tax Cuts and Jobs Act (the “Act”) was enacted into law. The legislation represents fundamental and dramatic modifications to the U.S. tax system. The Act contains several key tax provisions that will impact the Company’s U.S. subsidiaries, including the reduction of the maximum U.S. federal corporate income tax rate from 35% to 21%, effective January 1, 2018. Other significant changes under the Act include, among others, a one-time repatriation tax on accumulated foreign earnings, a limitation of net operating loss deduction to 80% of taxable income, and indefinite carryover of post-2017 net operating losses. The Act also repeals the corporate alternative minimum tax for tax years beginning after December 31, 2017. Losses generated prior to January 1, 2018 will still be subject to the 20-year carryforward limitation and the alternative minimum tax. Other potential impacts due to the Act include the repeal of the domestic manufacturing deduction, modification of taxation of controlled foreign corporations, a base erosion anti-abuse tax, modification of interest expense limitation rules, modification of limitation on deductibility of excessive executive compensation, and taxation of global intangible low-taxed income. The Company has evaluated the effect of the adoption of the Act on its financial statements and adjusted accordingly its tax rate for 2018 and beyond, therefore the impact of the change of the tax rate on the deferred tax assets net was recorded in 2017. g. Tax assessments: As of December 31, 2022, the Company had open tax years for the periods between 2017 and 2022 in Israel and for the periods between 2019 and 2022 for the U.S. subsidiaries. The Company has NOL in the U.S. from prior tax periods which may be subject to examination in future periods. h. Uncertain tax positions: A reconciliation of the opening and closing amounts of total unrecognized tax positions is as follows: December 31, 2022 2021 Opening balance $ 393 $ 221 Decrease related to previous years tax positions (393 ) - Increase related to previous years tax positions 590 - Increase related to current year tax positions 843 172 Closing balance $ 1,433 $ 393 The amount for the year ended December 31, 2022 includes $910 unrecognized tax benefits. The Company accrues interest and penalties related to unrecognized tax benefits in its provision for income taxes. |
Segment and geographic informat
Segment and geographic information | 12 Months Ended |
Dec. 31, 2022 | |
Segment Reporting [Abstract] | |
Segment and geographic information | Note 17: - Segment and geographic information Revenue attributable to the Company’s domicile and other geographic areas based on the location of the buyers was as follows for the years ended: December 31, 2022 2021 2020 U.S. $ 172,704 $ 154,360 $ 100,706 Europe 84,484 77,019 48,331 Asia Pacific 48,585 38,437 22,814 Rest of the world 28,153 24,991 15,715 Israel 3,440 2,855 1,944 $ 337,366 $ 297,662 $ 189,510 Property and equipment, net and ROU assets by geographical areas was as follows: December 31, 2022 2021 Israel $ 13,714 $ 16,175 U.S. and other 1,023 2,107 $ 14,737 $ 18,282 |
Subsequent events
Subsequent events | 12 Months Ended |
Dec. 31, 2022 | |
Subsequent Events [Abstract] | |
Subsequent events | Note 18: - Subsequent events The Company’s management evaluates subsequent events through the date of issuance of the consolidated financial statements. There have been no subsequent events that occurred during such period that would require adjustment to or disclosure in the consolidated financial statements as of and for the year ended December 31, 2022. |
Significant accounting polici_2
Significant accounting policies (Policies) | 12 Months Ended |
Dec. 31, 2022 | |
Accounting Policies [Abstract] | |
Use of estimates | a. Use of estimates: The preparation of consolidated financial statements, in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. The accounting estimates that require management’s subjective judgments include but are not limited to revenue recognition, income taxes, share-based compensation, purchase price allocation on acquisitions including determination of identifiable intangible assets of useful lives convertible notes borrowing rate, contingent consideration and impairment of intangible assets. The Company evaluates its estimates and judgments on an ongoing basis and revises them when necessary. Actual results may differ from the original or revised estimates. |
Principles of consolidation | b. Principles of consolidation: The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. Intercompany transactions and balances were eliminated upon consolidation. |
Functional currency | c. Functional currency: The functional currency of the Company is the U.S. dollar, as it is the currency of the primary economic environment in which the Company is operating. Foreign currency transactions and balances have been re-measured to U.S. dollars in accordance with Accounting Standard Codification (“ASC”) Topic 830, “Foreign Currency Matters.” All transaction gains and losses from re- measurement of monetary balance sheet items denominated in foreign currencies are recorded under financial income (expenses), net. |
Cash and cash equivalents and restricted cash: | d. Cash and cash equivalents and restricted cash: The Company considers all investments with an original maturity of three months or less at the time of purchase to be cash equivalents including amounts related to payment processing companies. Restricted cash includes cash that is legally restricted as to withdrawal or usage. |
Marketable securities | e. Marketable securities: The Company accounts for marketable securities in accordance with ASC Topic 320, “Investments – Debt and Equity Securities”. The Company’s investments in marketable securities consist of high-grade treasury, corporate and municipal bonds. Investments in marketable securities are classified as available for sale at the time of purchase. Available for sale securities are carried at fair value based on quoted market prices, with unrealized gains and losses, reported in accumulated other comprehensive income (loss) in shareholders’ equity. Realized gains and losses including interest and amortization of premium and discount arising from the acquisition of marketable securities were recorded under financial income (expenses), net. Following the adoption of ASC 326 the Company estimated expected credit losses for available for-sale debt securities in an unrealized loss position by considering a security’s probability of default and the recovery rate. The Company assessed the security’s credit indicators based on credit ratings. If the assessment indicates that an expected credit loss exists, the Company would determine the portion of the unrealized loss attributable to credit deterioration and would record an allowance for the expected credit loss. Unrealized gains and any portion of a security’s unrealized loss attributable to non-credit losses were recorded in other comprehensive income (loss). The Company has not recorded credit losses for the years ended December 31, 2022, 2021 and 2020. The Company classifies its marketable securities as either short term or long term based on each instrument’s underlying contractual maturity date as well as the intended time of realization. Marketable securities with maturities of 12 months or less are classified as short-term and marketable securities with maturities greater than 12 months are classified as long-term. On each reporting period the Company determines whether a decline in fair value below the amortized cost basis of an available for sale debt security is due to credit related factors or noncredit related factors. A credit related impairment would be recognized as an allowance on the balance sheet with a corresponding adjustment to earnings, however, if the Company would intend to sell an impaired available for sale debt security or more likely than not would be required to sell such a security before recovering its amortized cost basis, the entire impairment amount would be recognized in earnings with a corresponding adjustment to the security’s amortized cost basis. The Company did not recognize an allowance for credit losses on marketable securities as the expected losses were not material for the years ended December 31, 2022, 2021 and 2020. |
Bank deposits | f. Bank deposits: Deposits with maturities of more than three months but less than one year are classified as short term. Such deposits are presented at their cost. |
Restricted deposits | g. Restricted deposit: Restricted deposit is restricted as to withdrawal or use. The Company maintains restricted deposits mainly for the lease of the Company’s office space. |
Long-lived assets | h. Long-lived assets: The Company’s long-lived assets to be held and used are comprised of property and equipment, identifiable intangible assets and Right-Of-Use (“ROU”) assets. Property and equipment is stated at cost, net of accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets. Computers and peripheral equipment is amortized at an annual rate of 33%, office furniture and equipment is amortized at annual rate ranges from 7%-15% and leasehold and improvements amortized over the shortest of the term of the lease or the useful life of the asset. Intangible assets that are considered to have definite useful life are amortized using the straight-line basis over their estimated useful lives, which ranges from 2 to 10 years. Long lived assets that are considered to have definite useful life are tested for impairment in accordance with ASC Topic 360, “Property, Plant and Equipment” whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The Company’s evaluation of recoverability is performed at the lowest level to which identifiable cash flows are largely independent of the cash flows of other assets and liabilities, and represent an asset group. Recoverability of this asset group is measured by a comparison of the aggregate undiscounted projections of future cash flows the asset group is expected to generate to the carrying amounts of the asset group. If such evaluation indicates that the carrying amount of the asset group is not recoverable, an impairment is measured by the amount which the carrying amount of the asset group exceeds their fair value. During the second quarter of 2022 due to an adverse change in macro-economic conditions the Company recorded an impairment of intangible assets in the amount of $27,629 mainly in connection with the asset group related to Stoke acquisition, asset group related to CreativeLive acquisition and internal use software capitalization. In determining the estimated fair value of the asset group, the Company utilized a discounted cash flow model. The key assumptions within the model related to forecasting of future revenue, appropriate discount rate and appropriate terminal value based on the nature of the asset group. No impairment was recorded for the years ended December 31, 2021 and 2020. |
Internal-use software | i. Internal-use software: Costs incurred to develop internal-use software are capitalized and amortized over the estimated useful life of the software, which is generally three years. In accordance with ASC Topic, 350-40, “Internal-Use Software,” capitalization of costs to develop internal-use software begins when preliminary development efforts are successfully completed, the Company has committed project funding, it is probable that the project will be completed, and the software will be used as intended. Costs related to the design or maintenance of internal-use software are expensed as incurred. The Company periodically reviews internal-use software costs to determine whether the projects will be completed, placed in service, removed from service or replaced by other internally developed or third-party software. If the asset is not expected to provide any future benefit, the asset is retired, and any unamortized cost is expensed. Capitalized internal-use software costs are recorded under intangible assets. |
Business combinations | j. Business combinations: The results of an acquired business in a business combination are included in the Company’s consolidated financial statements from the date of acquisition according to the guidance of ASC Topic 805, “Business Combinations.” The Company allocates the purchase price, which is the sum of the consideration provided and may consist of cash, equity or a combination of the two, to the identifiable assets and liabilities of the acquired business at their fair values as of the acquisition date. The excess of the purchase price over the amount allocated to the identifiable assets and liabilities, if any, is recorded as goodwill. The estimated fair values and useful lives of identifiable intangible assets are based on many factors, including estimates and assumptions of future operating performance and cash flows of the acquired business, the nature of the business acquired and the specific characteristics of the identified intangible assets. The estimates and assumptions used to determine the fair values and useful lives of identified intangible assets could change due to numerous factors, including market conditions, technological developments, economic conditions and competition. Contingent consideration incurred in a business combination is included as part of the acquisition price and recorded at a probability weighted assessment of the fair value as of the acquisition date. The fair value of the contingent consideration is re-measured at each reporting period, with any adjustments in fair value recognized in earnings under general and administrative expenses. Acquisition related costs incurred by the Company are not included as a component of consideration transferred but are accounted for as an expense in the period in which the costs are incurred. |
Goodwill | k. Goodwill Goodwill represents the excess of the aggregate fair value of the consideration transferred in a business combination over the fair value of the assets acquired, net of liabilities assumed. Under ASC Topic 350, “Intangible—Goodwill and other,” goodwill is not amortized, but rather is subject to impairment test. ASC 350 allows an entity to first assess qualitative factors to determine whether it is necessary to perform a quantitative goodwill impairment test. If the qualitative assessment does not result in a more likely than not indication of impairment, no further impairment testing is required. If it does result in a more likely than not indication of impairment, a quantitative impairment test is performed. Alternatively, ASC 350 permits an entity to bypass the qualitative assessment for any reporting unit and proceed directly to performing the quantitative goodwill impairment test. The Company operates in one reporting segment, and this segment comprises its only reporting unit. The Company elected to perform an annual impairment test of goodwill as of October 1 st No goodwill impairment was recorded for the years ended December 31, 2022, 2021 and 2020. |
Derivatives and hedging | l. Derivatives and hedging: Derivatives are recognized at fair value as either assets or liabilities in the consolidated balance sheets in accordance with ASC Topic 815, “Derivatives and Hedging.” The gain or loss of derivatives which are designated and qualify as hedging instruments in a cash flow hedge, is recorded under accumulated other comprehensive income (loss) and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. The gain or loss in connection with forecasted transactions not probable of occurring was recorded under financial expenses, net. Derivatives are classified within Level 2 of the fair value hierarchy as the valuation inputs are based on quoted prices and market observable data of similar instruments. The Company entered into foreign currency cash flow hedges using forward, put and call option contracts to hedge certain forecasted payroll and other related payments denominated in NIS, to hedge against exchange rate fluctuations of the U.S. dollar. The Company recorded the cash flows associated with these derivatives under operating activities. |
Fair value of financial instruments | m. Fair value of financial instruments: The Company measures and discloses the fair value of financial assets and liabilities in accordance with ASC Topic 820, “Fair Value Measurement.” Fair value is based on the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The accounting standard establishes a fair value hierarchy that prioritizes observable and unobservable inputs used to measure fair value into three broad levels, which are described below: Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs. Level 2: Observable inputs that are based on inputs not quoted on active markets but corroborated by market data. Level 3: Unobservable inputs are used when little or no market data is available. |
Concentrations of credit risks | n. Concentrations of credit risks: Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, restricted cash, bank deposits, investment in marketable securities, restricted deposit and derivatives, which are placed in major banks in Israel, Germany and the U.S. User funds are held by a payment service provider which, pursuant to the agreement, was engaged to hold the user funds on behalf of buyers and sellers in an account segregated from the payment service provider’s operating bank account. The Company does not have off-balance sheet concentration of credit risks. |
Convertible notes | o. Convertible notes: Prior to January 1, 2022 the Company accounts for convertible notes in accordance with ASC Topic 815, “Derivatives and Hedging” and ASC Topic 470, “Debt”. The Company separately accounted for debt and equity components of convertible notes that may be settled in cash. The carrying amount of the debt component was based on the fair value of a similar hypothetical debt instrument excluding the conversion option. The equity component was based on the excess of the principal amount of the convertible notes over the fair value of the debt component after adjustment for an allocation of issuance costs. The equity component is recorded under additional paid in capital and is not remeasured as long as it continues to meet the criteria for equity classification. The difference between the principal amount of the convertible notes and the amount allocated to the debt component was considered to be debt discount, which is subsequently amortized through interest expenses over the expected life of the convertible notes using the effective interest method. Issuance costs were allocated to the debt and equity components in proportion to the allocation of proceeds to those components. Commencing January 1, 2022 after the adoption of ASU 2020-06 the Company accounted for the convertible notes as a single liability and did not present the equity component separately. |
Employee related obligations | p. Employee related obligations: The Company accounts for employee related obligations in accordance with ASC Topic 715, “Compensation—retirement benefits.” The Israeli Severance Pay Law, 1963 (“Severance Pay Law”), specifies that employees are entitled to severance payment, following the termination of their employment. Under the Severance Pay Law, the severance payment is calculated as one-month salary for each year of employment, or a portion thereof. The Company’s liability for severance pay is covered by the provisions of Section 14 of the Severance Pay Law (“Section 14”). Under Section 14 employees are entitled to monthly deposits, at a rate of 8.33% of their monthly salary, contributed on their behalf to their insurance funds. Payments made in accordance with Section 14 release the Company from any future severance payments in respect of those employees. As a result, the Company does not recognize any asset or liability in connection with severance pay. Severance costs amounted to $4,567, $4,549 and $3,081 for the years ended December 31, 2022, 2021 and 2020, respectively. The Company’s U.S. Subsidiaries have a 401(K) defined contribution plan covering certain employees in the U.S. The expenses recorded by the U.S. subsidiaries for matching contributions for the years ended December 31, 2022, 2021 and 2020 were immaterial. |
User funds and user accounts | q. User funds and user accounts: The Company has an arrangement with an existing payment service provider to hold funds on behalf of buyers and sellers (“users”). User funds consist of buyers’ prepayments, including the Company’s transaction and service fees that would be earned when an order is completed, credits issued upon cancellations and seller fees that have not yet been withdrawn. User accounts represent the corresponding liability to the users. The Company does not have ownership over the funds and does not have the right to direct the funds to be used at will or for its own benefit other than those funds related to transaction and service fees owed to the Company after control has been obtained by the customers. |
Leases | r. Leases: The Company determines if an arrangement meets the definition of a lease at the inception of the lease. ROU assets represent the right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease agreement. ROU asset is measured based on the discounted present value of the remaining lease payments, initial direct costs incurred and prepaid lease payments, excluding lease incentives. The lease liability is measured based on the discounted present value of the remaining lease payments. The discounted present value of remaining lease payments is computed using IBR based on the information available at the inception of the lease. The Company’s IBR was estimated to approximate the interest rate for collateralized borrowing with similar terms and payments and in economic environments where the leased asset was located. Lease term may include options to extend or terminate the lease when it is reasonably certain that the Company would exercise that option. The Company elected the practical expedient for lease agreements with a term of twelve months or less and does not recognized ROU assets and lease liabilities in respect of those agreements. Payments under the Company’s lease agreements are primarily fixed, however, certain lease agreements contain variable payments, which are expensed as incurred and not included in the operating lease ROU assets and liabilities. Variable lease payments are mainly comprised of payments affected by the consumer price index. The Company subleases certain office spaces to third parties. Sublease income is recognized over the term of the agreement. Lease expenses for lease payments are recognized on a straight-line basis over the lease term. The Company elected the practical expedient to not separate lease and non-lease components for its leases. |
Revenue | s. Revenue: The Company’s revenue was primarily comprised of transaction fees and service fees. The Company earns transaction fees for enabling orders and providing other services and service fees to cover administrative fees. The Company’s customers are the users on its platform. Users accept the Company’s terms of service upon registration to the platform. Gross order amount including transaction and service fees is collected from the buyer upfront by a third-party payment provider. The prepaid amounts from buyers are simultaneously recorded as an asset under user funds with a corresponding liability to buyers under user accounts and deferred revenue until the order is completed or canceled. A contract with a customer exists only when: the parties to the contract have approved it and are committed to perform their respective obligations, the Company can identify each party’s rights regarding the distinct services to be transferred (“performance obligations”), the Company can determine the transaction price for the services to be transferred, the contract has commercial substance and it is probable that the Company will collect the consideration to which it will be entitled in exchange for the services that will be transferred to the customer. The Company’s revenues are primarily comprised of one distinct performance obligation which is to arrange services to be provided (including communication, engagement and payment processing) on its marketplace platform by the sellers to the buyers. The Company earns transaction fees and service fees that are based on the total value of transactions ordered through the platform once the buyer obtains control of the service, which occurs at a point in time upon completion of each order. Revenue is recorded in the amount of consideration to which the Company expects to be entitled in exchange for performance obligations upon transfer of control to the customer, excluding amounts collected on behalf of other third parties and indirect taxes. Revenue is mainly recognized on a net basis since the Company has concluded that it acts as an agent on its platform, mainly since it does not take responsibility for the sellers’ services and therefore it is not primary responsible for fulfilling the promise to provide the service and doesn’t have discretion in price establishment. Therefore, the Company does not obtain control of the services before they are transferred to the customer. The Company elected to use the practical expedient and recognize the incremental costs of obtaining contracts as an expense since the amortization period of the assets that the Company otherwise would have recognized is one year or less. Similarly, the Company does not disclose the value of unsatisfied performance obligations since the original expected duration of the contracts is one year or less. The Company recognizes revenue from unused user accounts balances once the likelihood of the users exercising their unused accounts balances becomes remote and the Company is not required to remit such unused account balances to a third party in accordance with applicable unclaimed property laws. The amounts recognized for the year ended December 31, 2022, 2021 and 2020 were immaterial. Revenue from subscriptions including the Company’s content marketing platform, on line learning platform, creative talent platform and back-office platform are mainly recognized over time when the service is rendered to the customer. Revenue from the Company’s freelancer management platform is recognized at a point time upon the management service is rendered. Disaggregated revenue: The Company’s transaction fees for the years ended December 31, 2022, 2021 and 2020 were $250,846, $217,086 and $139,019, respectively. The Company’s services fees for the years ended December 31, 2022, 2021 and 2020 were $86,520, $80,576 and $50,491, respectively. Contract liabilities: The Company’s contract liabilities mainly consist of deferred revenues from transaction and service fees received in advance for services for which control has not been yet obtained by the customers. Deferred revenues amounted to $11,353 and $12,145 as of December 31, 2022 and 2021, respectively. |
Cost of revenue | t. Cost of revenue: Cost of revenue is mainly comprised of expenses related to payment processing companies’ fees, server hosting fees, costs of the Company’s customer support personnel, amortization of capitalized internal-use software, developed technology and courses. |
Research and development expenses | u. Research and development expenses: Research and development expenses are primarily comprised of costs of the Company’s research and development personnel and other development related expenses. Research and development costs are expensed as incurred, except to the extent that such costs are associated with internal-use software that qualifies for capitalization. |
Sales and marketing expenses | v. Sales and marketing expenses: Sales and marketing expenses are primarily comprised of costs of the Company’s marketing personnel, performance marketing investments, branding costs, amortization of customer relationships, creative relationships and trade name and other advertising costs. Sales and marketing expenses are expensed as incurred. Advertising costs were $119,519, $108,645 and $68,539 for the years ended December 31, 2022, 2021 and 2020, respectively. |
General and administrative expenses | w. General and administrative expenses: General and administrative expenses primarily include costs of the Company’s executive, finance, legal and other administrative personnel, costs associated with fraud risk reduction and others. General and administrative expenses are expensed as incurred. |
Share based compensation | x. Share based compensation: The Company accounts for share-based compensation in accordance with ASC Topic 718, “Compensation—Stock Compensation.” Share based awards are mainly granted to employees and members of the Company’s board of directors and measured at fair value at each grant date. The Company calculates the fair value of share options and Employee Share Purchase Plans (“ESPP”) on the date of grant using the Black-Scholes option-pricing model and the expense is recognized over the requisite service period for awards expected to vest using the straight line method. The Company recognizes the fair value of Restricted Share Units (“RSUs”) on the grant date based on the market value of the underlying share and the expense is recognized over the requisite service period for awards using the straight line method. The requisite service period for share options is generally four years. The Company recognizes forfeitures as they occur. The Black-Scholes option-pricing model requires the Company to make a number of assumptions including the fair value of our ordinary shares, expected volatility, expected term, risk-free interest rate and expected dividends. The Company evaluates the assumptions used to value share options and ESPP upon each grant date. Expected volatility of share options was calculated based on the Company’s volatility as well as the implied volatilities from market comparisons of certain publicly traded companies and other factors. Expected volatility for ESPP was calculated based upon the Company’s share prices. The expected share options term was calculated based on the simplified method, which uses the midpoint between the vesting date and the contractual term, as the Company does not have sufficient historical data to develop an estimate based on participant behavior. The risk-free interest rate was based on the U.S. treasury bonds yield with an equivalent term. The Company has not paid dividends and has no foreseeable plans to pay dividends. |
Income taxes | y. Income taxes: The Company accounts for income taxes in accordance with ASC Topic 740, “Accounting for Income Taxes,” using the liability method. Under the liability method, deferred assets and liabilities are recognized based upon anticipated future tax consequences attributable to differences between the financial statement carrying amounts of assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using the enacted tax rates that will be in effect for the years in which those tax assets are expected to be realized or settled. The Company regularly assesses the likelihood that its deferred tax assets will be realized from recoverable income taxes or recovered from future taxable income based on the realization criteria set forth in the relevant authoritative guidance. To the extent the Company believes any amounts are not more likely than not to be realized, the Company records a valuation allowance to reduce its deferred tax assets. The realization of deferred tax assets is dependent upon future earnings, if any, the timing and amount of which are uncertain. Accordingly, the net deferred tax assets have been fully offset by a valuation allowance. If the Company subsequently realizes or determines it is more likely than not that it will realize deferred tax assets that were previously determined to be unrealizable, the respective valuation allowance would be reversed, resulting in an adjustment to earnings in the period such determination is made. The Company recognizes uncertain tax positions based on its estimate of whether, and the extent to which, additional taxes will be due. These liabilities are established utilizing a two-step approach when the Company believes that certain positions might be challenged despite its belief that its tax return positions are fully supportable. The first step requires the Company to determine if the weight of available evidence indicates a tax position is more likely than not to be sustained upon audit. The second step is based on the largest amount of benefit, which is more likely than not to be realized on ultimate settlement. Any interest and penalties related to unrecognized tax benefits are recorded as income tax expense. The Company adjusts these liabilities in light of changing facts and circumstances, such as the outcome of a tax audit or changes in the tax law. |
Segment reporting | z. Segment reporting: The Company identifies operating segments in accordance with ASC Topic 280, “Segment Reporting” as components of an entity for which discrete financial information is available and is regularly reviewed by the chief operating decision maker, or decision-making group, in making decisions regarding resource allocation and evaluating financial performance. The Company defines the term “chief operating decision maker” to be its chief executive officer. The Company determined it operates in one operating segment and one reportable segment, as its chief operating decision maker reviews financial information presented only on a consolidated basis for purposes of allocating resources and evaluating financial performance. |
Loss per share | aa. Loss per share: The Company computes basic loss per share in accordance with ASC Topic 260, “Earnings per Share” by dividing the net loss attributable to ordinary shareholders by the weighted average number of ordinary shares outstanding during the year. Diluted loss per share is computed by taking into account the potential dilution that could occur upon the exercise of share options and ESPP and vesting of RSUs granted under share based compensation plans using the treasury stock method and the potential dilution that could occur upon conversion of the convertible notes using the if converted method. The potentially dilutive unvested RSUs, share options to purchase ordinary shares and potentially dilutive ordinary shares from conversion of convertible notes that were excluded from the computation amounted to 6,386,203 |
Contingencies | ab. Contingencies: The Company accrues for loss contingencies when losses become probable and are reasonably estimable. If the reasonable estimate of the loss is a range and no amount within the range is a better estimate, the minimum amount of the range is recorded as a liability. The Company does not accrue for contingent losses that, in its judgment, are considered to be reasonably possible, but not probable; however, it discloses the range of such reasonably possible losses. |
Recently adopted accounting pronouncements | ac. Recently adopted accounting pronouncements: In October 2021 the FASB ASU 2021-08, Topic 805 “Business Combinations” – Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. The amendments in this update require that an entity (acquirer) recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606. At the acquisition date, an acquirer should account for the related revenue contracts in accordance with Topic 606 as if it had originated the contracts. To achieve this, an acquirer may assess how the acquiree applied Topic 606 to determine what to record for the acquired revenue contracts. The amendments in this update are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The Company early adopted the standard in 2021. Acquisitions of businesses assumed during the year ended December 31, 2021 were presented in conformity with the provisions of the standard. |
Recently issued accounting pronouncements not yet adopted | In August 2020, the FASB issued ASU 2020-06, ASC Subtopic 470-20 “Debt—Debt with “Conversion and Other Options” and ASC subtopic 815- 40 “Hedging—Contracts in Entity’s Own Equity”. The standard reduced the number of accounting models for convertible debt instruments and convertible preferred stock. Convertible instruments that continue to be subject to separation models are those with embedded conversion features that are not clearly and closely related to the host contract, that meet the definition of a derivative, and that do not qualify for a scope exception from derivative accounting and convertible debt instruments issued with substantial premiums for which the premiums are recorded as paid-in capital. The amendments in this update are effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Company adopted this standard on January 1, 2022 using the modified retrospective approach. As of December 31, 2021 the adoption resulted in a reclassification of the equity component representing the conversion option of $78,157 from additional paid in capital to convertible notes and $21,033 from additional paid in capital to retained earnings. Interest expense would be reduced as a result of accounting for the convertible notes instrument as a single debt measured at its amortized cost. ad. Certain comparative figures have been reclassified to conform to the current year presentation. |
Certain comparative figures have been reclassified to conform to the current year presentation | ad. Certain comparative figures have been reclassified to conform to the current year presentation. |
Certain transactions (Tables)
Certain transactions (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Working Not Working, Inc. | |
Schedule of Fair Value of Consideration Transferred | T : Fair value Amortization period Cash and cash equivalents $ 910 Other tangible assets assumed 369 Creative relationships 4,252 10 years Customer relationships 812 2 years Trade name 362 3 years Goodwill 4,525 Total assets acquired 11,230 Total liabilities (1,308 ) Net assets acquired $ 9,922 |
Creative Live Inc | |
Schedule of Fair Value of Consideration Transferred | The table below summarizes the preliminary fair value of the acquired assets and assumed liabilities and the goodwill as of the acquisition date: Fair value Amortization period Cash and cash equivalents $ 2,066 Other tangible assets assumed 552 Courses 1,311 2 years Customer relationships 1,447 2 years Technology 1,522 4 years Trade name 557 5 years Goodwill 5,139 Total assets acquired 12,594 Deferred revenue and other liabilities assumed (3,262 ) Net assets acquired $ 9,332 The Company incurred approximately $121 in acquisition expenses for the year ended December 31, 2021 recorded under general and administrative expenses. Pro forma results of operations related to this acquisition have not been presented because they are not material to the Company’s consolidated statements of operations. c. Stoke Talent acquisition I . The results of operations of Stoke were consolidated in the Company’s financial statements commencing the date of acquisition. The agreement stipulated additional contingent payments to shareholders of Stoke in an aggregate amount of up to $15,000 subject to certain milestones to be paid after one year. The fair-value of the contingent consideration as of the acquisition date was $12,258 and measured based on the estimated future cash outflows, utilizing the Monte Carlo simulation. As of December 31, 2021 the liability was recorded under other non-current liabilities. During 2022 the Company reversed the liability since the corresponding milestones were not met . T : Cash paid $ 93,084 Fair value of contingent consideration 12,258 Fair value of unvested options 313 Total fair value of consideration transferred $ 105,655 The table below summarizes the fair value of the acquired assets and assumed liabilities and the resulting goodwill as of the acquisition date: Fair value Amortization period Cash and cash equivalents $ 12,278 Other tangible assets assumed 1,160 Developed technology 35,691 7 years Customer relationships 506 5 years Trade name 752 6 years Goodwill 56,367 Total assets acquired 106,754 Total liabilities assumed (1,099 ) Net assets acquired $ 105,655 |
Stoke Talent Ltd | |
Schedule of Fair Value of Acquired Assets and Assumed Liabilities | T : Cash paid $ 93,084 Fair value of contingent consideration 12,258 Fair value of unvested options 313 Total fair value of consideration transferred $ 105,655 |
Schedule of Fair Value of Consideration Transferred | The table below summarizes the fair value of the acquired assets and assumed liabilities and the resulting goodwill as of the acquisition date: Fair value Amortization period Cash and cash equivalents $ 12,278 Other tangible assets assumed 1,160 Developed technology 35,691 7 years Customer relationships 506 5 years Trade name 752 6 years Goodwill 56,367 Total assets acquired 106,754 Total liabilities assumed (1,099 ) Net assets acquired $ 105,655 |
Fair value of financial instr_2
Fair value of financial instruments (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Fair Value Disclosures [Abstract] | |
Schedule of Fair Value of Financial assets and liabilities Measurement | The following tables set forth the fair value of the Company’s financial assets and liabilities measured at fair value as of: December 31, 2022 Level 1 Level 2 Level 3 Cash and cash equivalents: Cash $ 52,558 $ - $ - Restricted cash 1,137 - - Money market funds 30,828 - - Bank deposits 3,366 - - Bank deposits 134,000 - - Restricted deposits 50 - - Marketable securities - 431,132 - Asset derivatives - 60 - Liability derivatives - (1,444 ) - $ 221,939 $ 429,748 $ - December 31, 2021 Level 1 Level 2 Level 3 Cash and cash equivalents: Cash $ 48,264 $ - $ - Restricted cash 2,919 - - Money market funds 19,091 - - Bank deposits 3,796 - - Bank deposits 134,000 - - Restricted deposits 50 - - Marketable securities - 435,674 - Asset derivatives - 822 - Liability derivatives - (4 ) - Contingent consideration - - (13,858 ) $ 208,120 $ 436,492 $ (13,858 ) |
Summary of Changes in Fair Value of Contingent Consideration | The following table sets forth a summary of the changes in the fair value of the contingent consideration: Fair value as of December 31, 2021 $ (13,858 ) Payment 1,609 Revaluation 12,249 Fair value as of December 31, 2022 $ - |
Marketable securities (Tables)
Marketable securities (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Investments, Debt and Equity Securities [Abstract] | |
Schedule of fair value, amortized cost and unrealized holding gains and losses of marketable securities | As of December 31, 2022, the amortized cost, unrealized holding gains and losses and fair value of marketable securities were as follows: Amortized Unrealized Unrealized Cost gains losses Fair Value Municipal and U.S. treasury bonds $ 77,005 $ 2 $ (2,559 ) $ 74,448 Corporate bonds 364,904 7 (8,227 ) 356,684 Total $ 441,909 $ 9 $ (10,786 ) $ 431,132 As of December 31, 2021, the amortized cost, unrealized holding gains and losses and fair value of marketable securities were as follows: Amortized Unrealized Unrealized Cost gains losses Fair Value Municipal and U.S. treasury bonds $ 47,325 $ 2 $ (237 ) $ 47,090 Corporate bonds 390,261 33 (1,710 ) 388,584 Total $ 437,586 $ 35 $ (1,947 ) $ 435,674 |
Schedule of fair value and amortized cost of the available-for-sale securities by contractual maturity | The following table summarizes the fair value and amortized cost of the available-for-sale securities by contractual maturity as of December 31, 2022: Amortized Fair Value Due within one year $ 245,615 $ 241,293 Due after one year through two years 196,294 189,839 Total $ 441,909 $ 431,132 |
Property and equipment, net (Ta
Property and equipment, net (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Property, Plant and Equipment [Abstract] | |
Schedule of Property and equipment, net | Property and equipment, net consisted of the following as of: December 31, 2022 2021 Leasehold improvements $ 6,271 $ 6,182 Computers and peripheral equipment 5,431 4,513 Office furniture and equipment 1,563 1,570 13,265 12,265 Less—accumulated depreciation (7,605 ) (5,710 ) $ 5,660 $ 6,555 |
Intangible assets, net (Tables)
Intangible assets, net (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Schedule of Intangible assets | The gross carrying amount of intangible assets net of impairment, net consisted of the following as of: December 31, 2022 2021 Developed technology $ 15,778 $ 41,133 Capitalized internal-use software 5,842 5,857 Customer relationships 4,335 5,425 Creative relationships 4,252 4,252 Trade name 2,035 2,841 Courses 890 1,312 Workforce 1,250 1,250 34,382 62,070 Less: Accumulated amortization and impairment ( 19,612 ) (12,849 ) Net carrying amount $ 14,770 $ 49,221 |
Schedule of Estimated Future Amortization Expense | The estimated future amortization of intangible assets as of December 31, 2022 was as follows: 2023 $ 4,168 2024 2,323 2025 2,040 2026 1,908 2027 and thereafter 4,331 $ 14,770 |
Derivatives and hedging (Tables
Derivatives and hedging (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Schedule of Gains and Losses Reclassified From Accumulated Other Comprehensive Loss to Statements of Operations | December 31, 2022 2021 2020 Cost of revenue $ 123 $ (35 ) $ (87 ) Research and development 2,640 (717 ) (655 ) Sales and marketing 1,025 (266 ) (311 ) General and administrative 294 (142 ) (214 ) $ 4,082 $ (1,160 ) $ (1,267 ) |
Other account payables and ac_2
Other account payables and accrued expenses (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Payables and Accruals [Abstract] | |
Schedule of Other Payable and Accrued Expenses | Other account payables and accrued expenses consisted of the following as of: December 31, 2022 2021 Accrued expenses and other $ 24,859 $ 23,659 Accrued payroll and government authorities 14,705 16,649 Tax withholding in connection with employees’ exercises of share options and vested RSUs 320 2,348 Contingent consideration - 1,600 Derivatives 1,444 4 $ 41,328 $ 44,260 |
Leases (Tables)
Leases (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Leases [Abstract] | |
Schedule of Components of Operating Lease Cost | The components of operating lease cost recorded under operating expenses for the year ended December 31, 2022 and 2021 were as follows: December 31, 2022 2021 2020 Fixed cost and variable cost that depend on an index $ 3,312 $ 3,258 3,192 Short term lease cost 23 136 277 Sublease income (434 ) (705 ) (792 ) $ 2,901 $ 2,689 2,677 |
Schedule of Lease Term and Discount Rate | Weighted average remaining lease term as of December 31, 2022 3.84 years Weighted average discount rate 2.3 % |
Schedule of Minimum Lease Payments | The minimum lease payments for the Company’s ROU assets over the remaining lease periods as of December 31, 2022, were as follows: 2023 $ 2,723 2024 2,275 2025 2,275 2026 2,275 2027 and after - Total undiscounted lease payments 9,548 Less: imputed interest (144 ) Present value of lease liabilities $ 9,404 |
Convertible notes (Tables)
Convertible notes (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Debt Disclosure [Abstract] | |
Schedule of Convertible Notes | The net carrying amount of convertible notes as of December 31, 2022 and 2021 were as follows: December 31, Debt component: 2022 2021 Principal amounts $ 460,000 $ 460,000 Unamortized discount - 85,478 Unamortized issuance costs 7,236 2,446 Net carrying amount $ 452,764 $ 372,076 Equity component, net $ - $ 99,190 |
Schedule of Interest Expense Related to Convertible Senior Notes | December 31, 2022 2021 2020 Amortization of discount $ - $ 19,473 3,677 Amortization of issuance costs 2,527 556 359 $ 2,527 $ 20,029 4,036 |
Long term loan and other non-_2
Long term loan and other non-current liabilities (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Debt Disclosure [Abstract] | |
Schedule of Long-term Loan and Other Long-term Liabilities | Long-term loan and other long-term liabilities consisted of the following as of: December 31, 2022 2021 Contingent consideration $ - $ 12,258 Other 1,559 841 $ 1,559 $ 13,099 |
Shareholders' equity (Tables)
Shareholders' equity (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Stockholders' Equity Note [Abstract] | |
Schedule of Status of Options | The following table summarizes the status of the share options as of and for the year ended: December 31, 2022 Number of Weighted- Weighted- contractual Outstanding at the beginning of the year 2,908,598 $ 47.85 6.04 Granted 560,060 61.91 Exercised (282,479 ) 12.99 Forfeited (89,965 ) 83.29 Outstanding at the end of the year 3,096,214 52.54 5.27 Exercisable at the end of the year 2,176,521 $ 32.85 5.07 |
Schedule of Fair Value of Options Estimated on Grant Date | The fair value of these share options was estimated on the grant date based on the following weighted average assumptions for the years ended: December 31, 2022 2021 2020 Volatility 54 57 50% – 55 46% – 50 Expected term in years 3.78 4.56 3.67 – 4.61 4.42 – 4.56 Risk-free interest rate 1.87% – 4.4% 0.43 1.11 0.2% – 1.41% Estimated fair value of underlying ordinary shares 27.55 – 81.03 170.35 – 323.10 27.90 – 158.89 Dividend yield 0% 0% 0% |
Schedule of Options Outstanding under 2011 Plan | The share options outstanding under the 2011 plan as of December 31, 2022, have been separated into exercise price groups as follows: Outstanding Exercisable Exercise price Number of Weighted Number of Weighted $0.00-$1.87 322,911 3.84 322,911 3.84 $1.88-$5.55 416,552 5.06 416,552 5.06 $5.56-$12.78 675,724 5.96 621,545 5.95 $12.79 -$23.08 179,960 6.12 167,805 6.14 $23.04-$25.82 381,891 3.83 305,925 3.80 $25.83-$35.35 262,031 6.60 15,883 6.30 $35.36-$81.03 246,299 4.82 132,684 4.76 $81.04-$186.75 248,276 5.98 51,884 5.98 $186.76-$236.86 220,496 5.59 73,687 5.58 $236.87-$323.10 142,074 5.13 67,645 5.13 Total 3,096,214 5.27 2,176,521 5.07 Aggregate intrinsic value $ 32,976 $ 31,722 |
Schedule of Status of RSU | The following table summarizes the status of RSUs as of and for the year ended: December 31, 2022 Number of Weighted- Outstanding at the beginning of the year 778,160 169.07 Granted 1,055,447 64.08 Vested (380,062 ) 132.55 Forfeited (317,417 ) 123.43 Outstanding at the end of the year 1,136,128 96.49 |
Schedule Of Fair Of Espp Weighted Average Assumptions | The fair value of ESPP was estimated on the grant date based on the following weighted average assumptions for the years ended: December 31, 2022 2021 2020 Volatility 86.4-97.6 % 86.0-86.4 % 61.9 Expected term in years 0.5 0.5 0.5 Risk-free interest rate 0.08-4.24 % 0.03-0.08 % 0.09 Estimated fair value of underlying ordinary shares 35.36-206.07 131.88-206.07 196.89 Dividend yield 0 % 0 % 0% |
Schedule of Stock-Based Compensation Costs | Share-based compensation costs are recorded in the consolidated statements of operations for the years ended: December 31, 2022 2021 2020 Cost of revenue $ 2,520 $ 1,436 $ 384 Research and development 23,828 20,008 5,842 Sales and marketing 17,196 14,106 3,084 General and administrative 28,211 19,857 6,505 $ 71,755 $ 55,407 $ 15,815 |
Financial income (expenses), _2
Financial income (expenses), net (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Component Of Other Non Operating Income Expense [Abstract] | |
Schedule of other Nonoperating income expense | Year ended December 31, 2022 2021 2020 Bank charges and other financial expenses $ (596 ) $ (134 ) $ (369 ) Amortization of discount and issuance costs of convertible notes (2,527 ) (20,029 ) (4,036 ) Derivatives and hedging (875 ) - - Exchange rate gain (loss), net 1,141 (1,273 ) (262 ) Interest income 6,481 1,923 1,867 $ 3,624 $ (19,513 ) $ (2,800 ) |
Income taxes (Tables)
Income taxes (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Income Tax Disclosure [Abstract] | |
Schedule of Domestic and Foreign Loss Before Income Taxes | The following are the domestic and foreign components of the Company’s loss before income taxes for the years ended: December 31, 2022 2021 2020 Domestic $ (62,905 ) $ (58,166 ) $ (11,097 ) Foreign (8,005 ) (6,687 ) (3,513 ) $ (70,910 ) $ (64,853 ) $ (14,610 ) |
Schedule of Components of Income Taxes | The following are the domestic and foreign components of the Company’s income taxes for the years ended: December 31, 2022 2021 2020 Domestic $ 632 $ - $ - Foreign (55 ) 159 200 $ 577 $ 159 $ 200 |
Schedule of Deferred Tax Assets | The principal components of the Company’s deferred tax assets are as follows for the years ended: December 31, 2022 2021 Deferred tax assets: Net operating loss carryforwards $ 38,850 $ 44,480 Research and development expenses carryforward 3,989 2,262 A 7,369 1,630 Share-based compensation 12,674 7,584 Operating lease liabilities 2,173 1,033 Issuance costs - 630 Total deferred tax asset $ 65,055 $ 57,619 Deferred tax liabilities: Operating lease ROU assets 2,097 998 Convertible notes 102 17,275 Acquired Intangible assets 1,060 2,253 Accrued and other 17 603 Total deferred tax liability $ 3,276 $ 21,129 Total deferred tax assets, net 61,779 36,490 Less—valuation allowance (61,779 ) (36,490 ) Total deferred tax assets, net of valuation allowance $ - $ - Based on the available evidence, management believes that it is more likely than not that certain of its deferred tax assets relating to net operating loss carryforwards and other temporary differences will not be realized and accordingly, a valuation allowance has been provided. d. The reconciliation of the Company’s theoretical income tax expense to actual income tax expense is as follows: Year ended December 31, 2022 2021 2020 Loss before income taxes $ (70,910 ) $ (64,853 ) $ (14,610 ) Statutory tax rate 23 % 23 % 23 % Theoretical tax benefit 16,309 14,916 3,360 Increase (decrease) in effective tax rate due to: Change in valuation allowance (4,491 ) (4,474 ) (2,558 ) Effect of entities with different tax rates (145 ) (28 ) (47) Non-deductible expenses (12,433 ) (11,501 ) (2,964 ) Impact of different tax rate on temporary differences - (462 ) (119 ) Excess tax benefit on stock based compensation 593 1,562 2,178 Uncertain tax provision (302 ) - - Other (108 ) (172 ) (50 ) Effective income taxes $ (577 ) $ (159 ) $ (200 ) e. Net operating loss carryforward: As of December 31, 2022, the Company had an indefinite Net Operating Losses (“NOL”) carryforward for Israeli tax purposes of approximately $96,864. This NOL carryforward can be carried forward and offset against taxable income. The Company also had a NOL carryforward for U.S. tax purposes of approximately $75,695 as of December 31, 2022. NOL’s for U.S. Federal income tax purposes (“Federal NOL’s”) generated in the years ended December 31, 2014 through 2017 will begin to expire in 2035 for federal income tax purposes. Federal NOL’s originating before January 1, 2018, are eligible to offset taxable income, if not otherwise limited under Internal Revenue Code (“IRC”) 382 limitations. Federal NOL’s generated after December 31, 2017, have an infinite carryforward period and are subject to 80% deduction limitation based upon pre-NOL deduction taxable income. All of the federal NOL’s of the Company are expected to be subject to certain limitations under 382 following that change in control that occurred upon acquisition of ClearVoice, Working Not Working, Inc. and CreativeLive. |
Schedule of Reconciliation Theoretical Income Tax Expense to Actual Income Tax Expense | d. The reconciliation of the Company’s theoretical income tax expense to actual income tax expense is as follows: Year ended December 31, 2022 2021 2020 Loss before income taxes $ (70,910 ) $ (64,853 ) $ (14,610 ) Statutory tax rate 23 % 23 % 23 % Theoretical tax benefit 16,309 14,916 3,360 Increase (decrease) in effective tax rate due to: Change in valuation allowance (4,491 ) (4,474 ) (2,558 ) Effect of entities with different tax rates (145 ) (28 ) (47) Non-deductible expenses (12,433 ) (11,501 ) (2,964 ) Impact of different tax rate on temporary differences - (462 ) (119 ) Excess tax benefit on stock based compensation 593 1,562 2,178 Uncertain tax provision (302 ) - - Other (108 ) (172 ) (50 ) Effective income taxes $ (577 ) $ (159 ) $ (200 ) |
Schedule of reconciliation of opening and closing amounts of total unrecognized tax positions | December 31, 2022 2021 Opening balance $ 393 $ 221 Decrease related to previous years tax positions (393 ) - Increase related to previous years tax positions 590 - Increase related to current year tax positions 843 172 Closing balance $ 1,433 $ 393 |
Segment and geographic inform_2
Segment and geographic information (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Segment Reporting [Abstract] | |
Schedule of Geographic Areas Based on Location | Revenue attributable to the Company’s domicile and other geographic areas based on the location of the buyers was as follows for the years ended: December 31, 2022 2021 2020 U.S. $ 172,704 $ 154,360 $ 100,706 Europe 84,484 77,019 48,331 Asia Pacific 48,585 38,437 22,814 Rest of the world 28,153 24,991 15,715 Israel 3,440 2,855 1,944 $ 337,366 $ 297,662 $ 189,510 |
Schedule of Long Lived Assets by Geographical Areas | Property and equipment, net and ROU assets by geographical areas was as follows: December 31, 2022 2021 Israel $ 13,714 $ 16,175 U.S. and other 1,023 2,107 $ 14,737 $ 18,282 |
Significant accounting polici_3
Significant accounting policies (Narrative) (Details) $ in Thousands | 6 Months Ended | 12 Months Ended | ||
Jun. 30, 2022 USD ($) | Dec. 31, 2022 USD ($) Segment shares | Dec. 31, 2021 USD ($) shares | Dec. 31, 2020 USD ($) shares | |
Percentage of monthly salary contributed to insurance funds | 8.33% | |||
Severance costs | $ 4,567 | $ 4,549 | $ 3,081 | |
Deferred revenues resulting from transaction and service fees | 11,353 | 12,145 | ||
Advertising costs | $ 119,519 | $ 108,645 | $ 68,539 | |
Potentially dilutive options to purchase ordinary shares | shares | 6,386,203 | 5,840,619 | 6,017,362 | |
Operating lease ROU assets | $ 9,077 | $ 11,727 | ||
Operating lease liabilities | 9,404 | |||
Reclassification of additional paid in capital to convertible notes | 78,157 | |||
Reclassification of additional paid in capital to retained earnings | $ 21,033 | |||
Impairment of long-lived assets | $ 27,629 | |||
Vesting period | 4 years | |||
Number of Reportable Segments | Segment | 1 | |||
Number of Operating Segments | Segment | 1 | |||
Computers and peripheral equipment | ||||
Property and equipment, net | 33% | |||
Leasehold improvements | ||||
Estimated useful lives | shortest of the term of the lease or the useful life of the asset | |||
Minimum | ||||
Intangible assets useful life | 2 years | |||
Minimum | Office furniture and equipment | ||||
Property and equipment, net | 7% | |||
Maximum | ||||
Intangible assets useful life | 10 years | |||
Maximum | Office furniture and equipment | ||||
Property and equipment, net | 15% | |||
Transaction Fee | ||||
Disaggregated revenue | $ 250,846 | 217,086 | $ 139,019 | |
Service | ||||
Disaggregated revenue | $ 86,520 | $ 80,576 | $ 50,491 |
Certain transactions (Acquisiti
Certain transactions (Acquisitions Narrative) (Details) - USD ($) $ in Thousands | 1 Months Ended | 12 Months Ended | |||
Nov. 30, 2021 | Oct. 31, 2021 | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Business Acquisition [Line Items] | |||||
Stock Issued During Period, Value, Acquisitions | $ 313 | ||||
Fair value of contingent consideration | $ 0 | 12,258 | $ 0 | ||
Other accrued expenses | 24,859 | 23,659 | |||
Other non-current liabilities | 460,972 | 395,658 | |||
Clear Voice, Inc. | |||||
Business Acquisition [Line Items] | |||||
Acquisition expenses | 97 | ||||
Stoke Talent Ltd | |||||
Business Acquisition [Line Items] | |||||
Total Consideration | 93,084 | ||||
Aggregate Retention Bonus | $ 15,000 | ||||
Fair value of contingent consideration | $ 12,258 | ||||
Creative Live Inc | |||||
Business Acquisition [Line Items] | |||||
Total Consideration | $ 9,332 | ||||
Aggregate Retention Bonus | 1,500 | ||||
Retention bonus expensed during period | 1,125 | $ 375 | |||
Acquisition expenses | 121 | ||||
Working Not Working, Inc. | |||||
Business Acquisition [Line Items] | |||||
Total Consideration | 9,922 | ||||
Aggregate Retention Bonus | 3,500 | ||||
Retention bonus expensed during period | 1,500 | ||||
Acquisition expenses | $ 292 |
Certain transactions (Schedule
Certain transactions (Schedule of Fair Value of Acquired Assets and Assumed Liabilities - Working Not Working acquisition) (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Business Acquisition [Line Items] | ||
Goodwill | $ 77,270 | $ 77,270 |
Working Not Working, Inc. | ||
Business Acquisition [Line Items] | ||
Cash and cash equivalents | 910 | |
Other tangible assets assumed | 369 | |
Goodwill | 4,525 | |
Total acquired assets | 11,230 | |
Total assumed liabilities | (1,308) | |
Net assets acquired | 9,922 | |
Working Not Working, Inc. | Creative relationships | ||
Business Acquisition [Line Items] | ||
Other tangible assets assumed | $ 4,252 | |
Finite-Lived Intangible Asset, Useful Life | 10 years | |
Working Not Working, Inc. | Customer relationships | ||
Business Acquisition [Line Items] | ||
Other tangible assets assumed | $ 812 | |
Finite-Lived Intangible Asset, Useful Life | 2 years | |
Working Not Working, Inc. | Trade name | ||
Business Acquisition [Line Items] | ||
Other tangible assets assumed | $ 362 | |
Finite-Lived Intangible Asset, Useful Life | 3 years |
Certain transactions (Schedul_2
Certain transactions (Schedule of Fair Value of Acquired Assets and Assumed Liabilities - Creative Live acquisition) (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Business Acquisition [Line Items] | ||
Goodwill | $ 77,270 | $ 77,270 |
Creative Live Inc | ||
Business Acquisition [Line Items] | ||
Cash and cash equivalents | 2,066 | |
Other tangible assets assumed | 552 | |
Goodwill | 5,139 | |
Total assets acquired | 12,594 | |
Total assumed liabilities | (3,262) | |
Net assets acquired | 9,332 | |
Creative Live Inc | Courses | ||
Business Acquisition [Line Items] | ||
Net assets acquired | $ 1,311 | |
Estimated amortization period | 2 years | |
Creative Live Inc | Customer relationships | ||
Business Acquisition [Line Items] | ||
Other tangible assets assumed | $ 1,447 | |
Estimated amortization period | 2 years | |
Creative Live Inc | Developed technology | ||
Business Acquisition [Line Items] | ||
Net assets acquired | $ 1,522 | |
Estimated amortization period | 4 years | |
Creative Live Inc | Trade name | ||
Business Acquisition [Line Items] | ||
Net assets acquired | $ 557 | |
Estimated amortization period | 5 years |
Certain transactions (Schedul_3
Certain transactions (Schedule of Fair Value of Consideration Transferred to Stoke Shareholders) (Details) - Stoke Talent Ltd $ in Thousands | 12 Months Ended |
Dec. 31, 2022 USD ($) | |
Business Acquisition [Line Items] | |
Cash paid | $ 93,084 |
Fair-value of contingent consideration | 12,258 |
Fair value of unvested options | 313 |
Total fair value of consideration transferred | $ 105,655 |
Certain transactions (Schedul_4
Certain transactions (Schedule of Fair Value of Acquired Assets and Assumed Liabilities - Stoke acquisition) (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Business Acquisition [Line Items] | ||
Goodwill | $ 77,270 | $ 77,270 |
Stoke Talent Ltd | ||
Business Acquisition [Line Items] | ||
Cash and cash equivalents | 12,278 | |
Intangible assets | 1,160 | |
Goodwill | 56,367 | |
Total acquired assets | 106,754 | |
Total assumed liabilities | (1,099) | |
Net assets acquired | 105,655 | |
Stoke Talent Ltd | Developed technology | ||
Business Acquisition [Line Items] | ||
Intangible assets | $ 35,691 | |
Estimated amortization period | 7 years | |
Stoke Talent Ltd | Customer relationships | ||
Business Acquisition [Line Items] | ||
Intangible assets | $ 506 | |
Estimated amortization period | 5 years | |
Stoke Talent Ltd | Trade name | ||
Business Acquisition [Line Items] | ||
Intangible assets | $ 752 | |
Estimated amortization period | 6 years |
Fair value of financial instr_3
Fair value of financial instruments (Narrative) (Details) $ in Thousands | Dec. 31, 2022 USD ($) |
Over-The-Counter Market | Level 2 | |
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | |
Estimated fair value of convertible notes | $ 373,428 |
Fair value of financial instr_4
Fair value of financial instruments (Schedule of Fair Value of Financial Assets Measurement) (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Contingent consideration | $ 0 | $ (13,858) |
Level 1 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities | 0 | 0 |
Asset derivatives | 0 | 0 |
Liability derivatives | 0 | 0 |
Contingent consideration | 0 | |
Financial assets (liabilities) measured at fair value | 221,939 | 208,120 |
Level 2 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities | 431,132 | 435,674 |
Asset derivatives | 60 | 822 |
Liability derivatives | (1,444) | (4) |
Contingent consideration | 0 | |
Financial assets (liabilities) measured at fair value | 429,748 | 436,492 |
Level 3 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities | 0 | 0 |
Asset derivatives | 0 | 0 |
Liability derivatives | 0 | 0 |
Contingent consideration | (13,858) | |
Financial assets (liabilities) measured at fair value | 0 | (13,858) |
Cash | Level 1 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash and cash equivalents | 52,558 | 48,264 |
Cash | Level 2 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash and cash equivalents | 0 | 0 |
Cash | Level 3 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash and cash equivalents | 0 | 0 |
Restricted cash | Level 1 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash and cash equivalents | 1,137 | 2,919 |
Restricted cash | Level 2 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash and cash equivalents | 0 | 0 |
Restricted cash | Level 3 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash and cash equivalents | 0 | 0 |
Money market funds | Level 1 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash and cash equivalents | 30,828 | 19,091 |
Money market funds | Level 2 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash and cash equivalents | 0 | 0 |
Money market funds | Level 3 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash and cash equivalents | 0 | 0 |
Bank deposits | Level 1 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash and cash equivalents | 3,366 | 3,796 |
Bank deposits | Level 2 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash and cash equivalents | 0 | 0 |
Bank deposits | Level 3 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash and cash equivalents | 0 | 0 |
Bank deposits | Level 1 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash and cash equivalents | 134,000 | 134,000 |
Bank deposits | Level 2 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash and cash equivalents | 0 | 0 |
Bank deposits | Level 3 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash and cash equivalents | 0 | 0 |
Restricted deposits | Level 1 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash and cash equivalents | 50 | 50 |
Restricted deposits | Level 2 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash and cash equivalents | 0 | 0 |
Restricted deposits | Level 3 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash and cash equivalents | $ 0 | $ 0 |
Fair value of financial instr_5
Fair value of financial instruments (Summary of Changes in Fair Value of Contingent Consideration) (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Fair Value Disclosures [Abstract] | |||
Fair value as of December 31, 2020 | $ (13,858) | ||
Payment | 1,609 | ||
Revaluation | 12,249 | $ (11,771) | $ (398) |
Fair value as of December 31, 2021 | $ 0 | $ (13,858) |
Marketable securities (Schedule
Marketable securities (Schedule of fair value, amortized cost and unrealized holding gains and losses of marketable securities) (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | $ 441,909 | $ 437,586 |
Unrealized gains | 9 | 35 |
Unrealized losses | (10,786) | (1,947) |
Debt Securities, Available-for-sale | 431,132 | 435,674 |
Municipal And US Treasury Bond Securities | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | 77,005 | 47,325 |
Unrealized gains | 2 | 2 |
Unrealized losses | (2,559) | (237) |
Debt Securities, Available-for-sale | 74,448 | 47,090 |
Corporate bonds | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | 364,904 | 390,261 |
Unrealized gains | 7 | 33 |
Unrealized losses | (8,227) | (1,710) |
Debt Securities, Available-for-sale | $ 356,684 | $ 388,584 |
Marketable securitiesMarketable
Marketable securitiesMarketable securities (Schedule of fair value and amortized cost of the available-for-sale securities by contractual maturity) (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Amortized Cost | ||
Due within one year | $ 245,615 | |
Due after one year through two years | 196,294 | |
Total | 441,909 | |
Fair Value | ||
Due within one year | 241,293 | |
Due after one year through two years | 189,839 | |
Total | $ 431,132 | $ 435,674 |
Property and equipment, net (Na
Property and equipment, net (Narrative) (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Property, Plant and Equipment [Abstract] | |||
Depreciation expenses | $ 2,032 | $ 1,739 | $ 1,207 |
Property and equipment, net (Sc
Property and equipment, net (Schedule of Property and equipment, net) (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Property, Plant and Equipment [Line Items] | ||
Property and equipment, gross | $ 13,265 | $ 12,265 |
Less-accumulated depreciation | (7,605) | (5,710) |
Property and equipment, net | 5,660 | 6,555 |
Leasehold improvements | ||
Property, Plant and Equipment [Line Items] | ||
Property and equipment, gross | 6,271 | 6,182 |
Computers and peripheral equipment | ||
Property, Plant and Equipment [Line Items] | ||
Property and equipment, gross | 5,431 | 4,513 |
Office furniture and equipment | ||
Property, Plant and Equipment [Line Items] | ||
Property and equipment, gross | $ 1,563 | $ 1,570 |
Intangible assets, net (Narrati
Intangible assets, net (Narrative) (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |||
Capitalized amount | $ 953 | $ 1,261 | $ 577 |
Share-based compensation capitalized | 274 | 247 | 40 |
Amortization expenses | 8,153 | 5,137 | 3,131 |
Payments to Acquire Intangible Assets | $ 175 | $ 0 | $ 1,230 |
Intangible assets, net (Schedul
Intangible assets, net (Schedule of Intangible assets, net) (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Finite-Lived Intangible Assets [Line Items] | ||
Intangible assets, gross | $ 34,382 | $ 62,070 |
Less: Accumulated amortization and impairment | (19,612) | (12,849) |
Intangible assets, net | 14,770 | 49,221 |
Developed technology | ||
Finite-Lived Intangible Assets [Line Items] | ||
Intangible assets, gross | 15,778 | 41,133 |
Capitalized internal-use software | ||
Finite-Lived Intangible Assets [Line Items] | ||
Intangible assets, gross | 5,842 | 5,857 |
Customer relationships | ||
Finite-Lived Intangible Assets [Line Items] | ||
Intangible assets, gross | 4,335 | 5,425 |
Creative relationships | ||
Finite-Lived Intangible Assets [Line Items] | ||
Intangible assets, gross | 4,252 | 4,252 |
Trade name | ||
Finite-Lived Intangible Assets [Line Items] | ||
Intangible assets, gross | 2,035 | 2,841 |
Courses | ||
Finite-Lived Intangible Assets [Line Items] | ||
Intangible assets, gross | 890 | 1,312 |
Workforce | ||
Finite-Lived Intangible Assets [Line Items] | ||
Intangible assets, gross | $ 1,250 | $ 1,250 |
Intangible assets, net (Sched_2
Intangible assets, net (Schedule of estimated future amortization of intangible assets) (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Goodwill and Intangible Assets Disclosure [Abstract] | ||
2023 | $ 4,168 | |
2024 | 2,323 | |
2025 | 2,040 | |
2026 | 1,908 | |
2027 and thereafter | 4,331 | |
Total | $ 14,770 | $ 49,221 |
Derivatives and hedging (Narrat
Derivatives and hedging (Narrative) (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Derivative Instruments, Gain (Loss) [Line Items] | |||
Amounts reclassified from accumulated other comprehensive loss | $ 4,082 | $ (1,160) | $ (1,267) |
Losses reclassified from other comprehensive loss to financial expenses | 875 | ||
Foreign Exchange Contract | Designated as Hedging Instrument | |||
Derivative Instruments, Gain (Loss) [Line Items] | |||
Notional amount | 64,000 | 49,620 | |
Fair value of outstanding put and call option forward contracts, asset | 60 | 822 | |
Fair value of outstanding put and call option forward contracts, liability | $ 1,444 | $ 4 |
Derivatives and hedging (Schedu
Derivatives and hedging (Schedule of Losses Reclassified From Accumulated Other Comprehensive Loss) (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Derivative Instruments and Hedging Activities Disclosures [Line Items] | |||
Amounts reclassified from accumulated other comprehensive loss | $ 4,082 | $ (1,160) | $ (1,267) |
Cost of revenue | |||
Derivative Instruments and Hedging Activities Disclosures [Line Items] | |||
Amounts reclassified from accumulated other comprehensive loss | 123 | (35) | (87) |
Research and development | |||
Derivative Instruments and Hedging Activities Disclosures [Line Items] | |||
Amounts reclassified from accumulated other comprehensive loss | 2,640 | (717) | (655) |
Sales and marketing | |||
Derivative Instruments and Hedging Activities Disclosures [Line Items] | |||
Amounts reclassified from accumulated other comprehensive loss | 1,025 | (266) | (311) |
General and administrative | |||
Derivative Instruments and Hedging Activities Disclosures [Line Items] | |||
Amounts reclassified from accumulated other comprehensive loss | $ 294 | $ (142) | $ (214) |
Other account payables and ac_3
Other account payables and accrued expenses (Schedule of Other Payable and Accrued Expenses) (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Payables and Accruals [Abstract] | ||
Accrued expenses and other | $ 24,859 | $ 23,659 |
Accrued payroll and government authorities | 14,705 | 16,649 |
Tax withholding in connection with employees' exercises of share options and vested RSUs | 320 | 2,348 |
Contingent consideration | 0 | 1,600 |
Other | 1,444 | 4 |
Total | $ 41,328 | $ 44,260 |
Leases (Schedule of Components
Leases (Schedule of Components of Operating Lease Cost) (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Leases [Abstract] | |||
Fixed cost and variable cost that depend on an index | $ 3,312 | $ 3,258 | $ 3,192 |
Short term lease cost | 23 | 136 | 277 |
Sublease income | (434) | (705) | (792) |
Total lease cost | $ 2,901 | $ 2,689 | $ 2,677 |
Leases (Schedule of Lease Term
Leases (Schedule of Lease Term and Discount Rate) (Details) | Dec. 31, 2022 |
Leases [Abstract] | |
Weighted average remaining lease term as of December 31, 2022 | 3 years 10 months 2 days |
Weighted average discount rate | 2.30% |
Leases (Schedule of Minimum Lea
Leases (Schedule of Minimum Lease Payments) (Details) $ in Thousands | Dec. 31, 2022 USD ($) |
Leases [Abstract] | |
2023 | $ 2,723 |
2024 | 2,275 |
2025 | 2,275 |
2026 | 2,275 |
2027 and after | 0 |
Total undiscounted lease payments | 9,548 |
Less: imputed interest | (144) |
Present value of lease liabilities | $ 9,404 |
Convertible notes (Narrative) (
Convertible notes (Narrative) (Details) $ / shares in Units, $ in Thousands | 1 Months Ended | ||
Oct. 31, 2020 USD ($) Days $ / shares $ / share | Dec. 31, 2022 USD ($) $ / shares | Dec. 31, 2021 USD ($) $ / shares | |
Debt Conversion [Line Items] | |||
Convertible notes | $ 460,000 | $ 460,000 | $ 460,000 |
Coupon rate | 0% | ||
Initial conversion rate | $ / shares | $ 4.6823 | ||
Ordinary shares, par value | $ / shares | 1 | $ 0 | $ 0 |
Conversion price | $ / shares | $ 213.57 | ||
Maturity date | Nov. 01, 2025 | ||
Debt conversion terms | Prior t | ||
Redemption date of convertible notes | Nov. 05, 2023 | ||
Percentage of conversion price | 130% | ||
Debt trading days | Days | 20 | ||
Debt consecutive trading days | Days | 30 | ||
Percentage of debt redemtion | 100% | ||
Payments of debt issuance costs | $ 9,969 | ||
Payments of stock issuance costs | $ 2,842 | ||
Effective borrowing rate of convertible notes | 5.10% | 0.56% | |
Capped Call | |||
Debt Conversion [Line Items] | |||
Derivative initial strike price | $ / share | 213.57 | ||
Derivative cap price | $ / share | 305.1 | ||
Capped call transactions | $ 43,240 | ||
Over-Allotment Option | |||
Debt Conversion [Line Items] | |||
Convertible notes | $ 60,000 |
Convertible notes (Schedule of
Convertible notes (Schedule of Convertible Notes) (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 | Oct. 31, 2020 |
Liability Component [Abstract] | |||
Principal amounts | $ 460,000 | $ 460,000 | $ 460,000 |
Unamortized discount | 0 | 85,478 | |
Unamortized issuance costs | 7,236 | 2,446 | |
Net carrying amount | 452,764 | 372,076 | |
Equity component, net | $ 0 | $ 99,190 |
Convertible notes (Schedule o_2
Convertible notes (Schedule of Interest Expense Related to Convertible Senior Notes) (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Debt Disclosure [Abstract] | |||
Amortization of discount | $ 0 | $ 19,473 | $ 3,677 |
Amortization of issuance costs | 2,527 | 556 | 359 |
Financial expense on convertible senior notes | $ 2,527 | $ 20,029 | $ 4,036 |
Long term loan and other non-_3
Long term loan and other non-current liabilities (Schedule of Long-term Loan and Other Long-term Liabilities) (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Debt Disclosure [Abstract] | ||
Contingent consideration | $ 0 | $ 12,258 |
Other | 1,559 | 841 |
Long-term loan and other non-current liabilities | $ 1,559 | $ 13,099 |
Shareholders' equity (Narrative
Shareholders' equity (Narrative) (Details) - USD ($) $ / shares in Units, $ in Thousands | 12 Months Ended | |||
Jun. 02, 2020 | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Proceeds from follow-on offering, net | $ 0 | $ 0 | $ 129,853 | |
Vesting period | 4 years | |||
Weighted-average grant-date fair value of options granted | $ 25.24 | $ 130.95 | $ 27.85 | |
Aggregate intrinsic value of exercised options | $ 10,873 | $ 142,419 | $ 128,463 | |
Grant-date fair value of vested options | 23,346 | $ 25,536 | $ 12,620 | |
Total unrecognized compensation cost | $ 144,610 | |||
Total unrecognized compensation cost weighted-average period | 2 years 6 months 18 days | |||
2019 Plan | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Vesting period | 4 years | |||
Unallocated ordinary shares | 3,551,789 | |||
IPO | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Issuance of ordinary shares, net of issuance costs (shares) | 2,300,000 | |||
Proceeds from follow-on offering, net | $ 129,853 | |||
IPO | Underwriters | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Issuance of ordinary shares, net of issuance costs (shares) | 300,000 | |||
ESPP | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Issuance of ordinary shares, net of issuance costs (shares) | 142,973 | |||
Number of ordinary shares reserved and available for grant and issuance | 701,205 | |||
Percentage number of shares available for issuance | 1% | |||
Percentage of employee salaries to purchase ordinary shares | 15% | |||
Percentage price of ordinary share purchased of fair market value | 85% |
Shareholders' equity (Schedule
Shareholders' equity (Schedule of Status of Options) (Details) - $ / shares | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Number of share options | ||
Outstanding at the beginning of the year | 2,908,598 | |
Granted | 560,060 | |
Exercised | (282,479) | |
Forfeited | (89,965) | |
Outstanding at the end of the year | 3,096,214 | 2,908,598 |
Exercisable at the end of the year | 2,176,521 | |
Weighted-average exercise price | ||
Outstanding at the beginning of the year | $ 47.85 | |
Granted | 61.91 | |
Exercised | 12.99 | |
Forfeited | 83.29 | |
Outstanding at the end of the year | 52.54 | $ 47.85 |
Exercisable at the end of the year | $ 32.85 | |
Weighted-average remaining contractual term (in years) | ||
Outstanding | 5 years 3 months 7 days | 6 years 14 days |
Exercisable at the end of the year | 5 years 25 days |
Shareholders' equity (Schedul_2
Shareholders' equity (Schedule of Fair Value of Options Estimated on Grant Date) (Details) - $ / shares | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Dividend yield | 0% | 0% | 0% |
Minimum | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Volatility | 54% | 50% | 46% |
Expected term in years | 3 years 9 months 10 days | 3 years 8 months 1 day | 4 years 5 months 1 day |
Risk-free interest rate | 1.87% | 0.43% | 0.20% |
Estimated fair value of underlying ordinary shares | $ 27.55 | $ 170.35 | $ 27.9 |
Maximum | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Volatility | 57% | 55% | 50% |
Expected term in years | 4 years 6 months 21 days | 4 years 7 months 9 days | 4 years 6 months 21 days |
Risk-free interest rate | 4.40% | 1.11% | 1.41% |
Estimated fair value of underlying ordinary shares | $ 81.03 | $ 323.1 | $ 158.89 |
Shareholders' equity (Schedul_3
Shareholders' equity (Schedule of Options Outstanding under 2011 Plan and 2011 Sub-Plan) (Details) - 2011 plan $ / shares in Units, $ in Thousands | 12 Months Ended |
Dec. 31, 2022 USD ($) $ / shares shares | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Outstanding Number of share options | 3,096,214 |
Outstanding Weighted average remaining contractual life (in years) | 5 years 3 months 7 days |
Exercisable Number of share options | 2,176,521 |
Exercisable Weighted average remaining contractual life (years) | 5 years 25 days |
Outstanding Aggregate intrinsic value | $ | $ 32,976 |
Exercisable Aggregate intrinsic value | $ | $ 31,722 |
$0.00-$1.87 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Outstanding Number of share options | 322,911 |
Outstanding Weighted average remaining contractual life (in years) | 3 years 10 months 2 days |
Exercisable Number of share options | 322,911 |
Exercisable Weighted average remaining contractual life (years) | 3 years 10 months 2 days |
$0.00-$1.87 | Minimum | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Exercise price | $ / shares | $ 0 |
$0.00-$1.87 | Maximum | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Exercise price | $ / shares | $ 1.87 |
$0.00-$1.87 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Outstanding Number of share options | 416,552 |
Outstanding Weighted average remaining contractual life (in years) | 5 years 21 days |
Exercisable Number of share options | 416,552 |
Exercisable Weighted average remaining contractual life (years) | 5 years 21 days |
$0.00-$1.87 | Minimum | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Exercise price | $ / shares | $ 1.88 |
$0.00-$1.87 | Maximum | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Exercise price | $ / shares | $ 5.55 |
$5.56-$12.78 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Outstanding Number of share options | 675,724 |
Outstanding Weighted average remaining contractual life (in years) | 5 years 11 months 15 days |
Exercisable Number of share options | 621,545 |
Exercisable Weighted average remaining contractual life (years) | 5 years 11 months 12 days |
$5.56-$12.78 | Minimum | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Exercise price | $ / shares | $ 5.56 |
$5.56-$12.78 | Maximum | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Exercise price | $ / shares | $ 12.78 |
$12.79 -$23.08 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Outstanding Number of share options | 179,960 |
Outstanding Weighted average remaining contractual life (in years) | 6 years 1 month 13 days |
Exercisable Number of share options | 167,805 |
Exercisable Weighted average remaining contractual life (years) | 6 years 1 month 20 days |
$12.79 -$23.08 | Minimum | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Exercise price | $ / shares | $ 12.79 |
$12.79 -$23.08 | Maximum | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Exercise price | $ / shares | $ 23.08 |
$23.04-$25.82 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Outstanding Number of share options | 381,891 |
Outstanding Weighted average remaining contractual life (in years) | 3 years 9 months 29 days |
Exercisable Number of share options | 305,925 |
Exercisable Weighted average remaining contractual life (years) | 3 years 9 months 18 days |
$23.04-$25.82 | Minimum | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Exercise price | $ / shares | $ 23.04 |
$23.04-$25.82 | Maximum | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Exercise price | $ / shares | $ 25.82 |
$25.83-$35.35 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Outstanding Number of share options | 262,031 |
Outstanding Weighted average remaining contractual life (in years) | 6 years 7 months 6 days |
Exercisable Number of share options | 15,883 |
Exercisable Weighted average remaining contractual life (years) | 6 years 3 months 18 days |
$25.83-$35.35 | Minimum | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Exercise price | $ / shares | $ 25.83 |
$25.83-$35.35 | Maximum | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Exercise price | $ / shares | $ 35.35 |
$35.36-$81.03 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Outstanding Number of share options | 246,299 |
Outstanding Weighted average remaining contractual life (in years) | 4 years 9 months 25 days |
Exercisable Number of share options | 132,684 |
Exercisable Weighted average remaining contractual life (years) | 4 years 9 months 3 days |
$35.36-$81.03 | Minimum | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Exercise price | $ / shares | $ 35.36 |
$35.36-$81.03 | Maximum | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Exercise price | $ / shares | $ 81.03 |
$81.04-$186.75 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Outstanding Number of share options | 248,276 |
Outstanding Weighted average remaining contractual life (in years) | 5 years 11 months 23 days |
Exercisable Number of share options | 51,884 |
Exercisable Weighted average remaining contractual life (years) | 5 years 11 months 23 days |
$81.04-$186.75 | Minimum | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Exercise price | $ / shares | $ 81.04 |
$81.04-$186.75 | Maximum | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Exercise price | $ / shares | $ 186.75 |
$186.76-$236.86 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Outstanding Number of share options | 220,496 |
Outstanding Weighted average remaining contractual life (in years) | 5 years 7 months 2 days |
Exercisable Number of share options | 73,687 |
Exercisable Weighted average remaining contractual life (years) | 5 years 6 months 29 days |
$186.76-$236.86 | Minimum | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Exercise price | $ / shares | $ 186.76 |
$186.76-$236.86 | Maximum | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Exercise price | $ / shares | $ 236.86 |
$236.87-$323.10 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Outstanding Number of share options | 142,074 |
Outstanding Weighted average remaining contractual life (in years) | 5 years 1 month 17 days |
Exercisable Number of share options | 67,645 |
Exercisable Weighted average remaining contractual life (years) | 5 years 1 month 17 days |
$236.87-$323.10 | Minimum | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Exercise price | $ / shares | $ 236.87 |
$236.87-$323.10 | Maximum | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Exercise price | $ / shares | $ 323.1 |
Shareholders' equity (Schedul_4
Shareholders' equity (Schedule of Status of RSU) (Details) - RSUs | 12 Months Ended |
Dec. 31, 2022 $ / shares shares | |
Number of RSUs | |
Outstanding at the beginning of the year | shares | 778,160 |
Granted | shares | 1,055,447 |
Vested | shares | (380,062) |
Forfeited | shares | (317,417) |
Outstanding at the end of the year | shares | 1,136,128 |
Weighted-average grant date fair value | |
Outstanding at the beginning of the year | $ / shares | $ 169.07 |
Granted | $ / shares | 64.08 |
Vested | $ / shares | 132.55 |
Forfeited | $ / shares | 123.43 |
Outstanding at the end of the year | $ / shares | $ 96.49 |
Shareholders' equity (Schedul_5
Shareholders' equity (Schedule of Fair Of ESPP Weighted Average Assumptions) (Details) - $ / shares | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Dividend yield | 0% | 0% | 0% |
Minimum | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Volatility | 54% | 50% | 46% |
Expected term in years | 3 years 9 months 10 days | 3 years 8 months 1 day | 4 years 5 months 1 day |
Risk-free interest rate | 1.87% | 0.43% | 0.20% |
Estimated fair value of underlying ordinary shares | $ 27.55 | $ 170.35 | $ 27.9 |
Maximum | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Volatility | 57% | 55% | 50% |
Expected term in years | 4 years 6 months 21 days | 4 years 7 months 9 days | 4 years 6 months 21 days |
Risk-free interest rate | 4.40% | 1.11% | 1.41% |
Estimated fair value of underlying ordinary shares | $ 81.03 | $ 323.1 | $ 158.89 |
ESPP | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Volatility | 61.90% | ||
Expected term in years | 6 months | 6 months | 6 months |
Risk-free interest rate | 0.09% | ||
Estimated fair value of underlying ordinary shares | $ 196.89 | ||
Dividend yield | 0% | 0% | 0% |
ESPP | Minimum | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Volatility | 86.40% | 86% | |
Risk-free interest rate | 0.08% | 0.03% | |
Estimated fair value of underlying ordinary shares | $ 35.36 | $ 131.88 | |
ESPP | Maximum | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Volatility | 97.60% | 86.40% | |
Risk-free interest rate | 4.24% | 0.08% | |
Estimated fair value of underlying ordinary shares | $ 206.07 | $ 206.07 |
Shareholders' equity (Schedul_6
Shareholders' equity (Schedule of Stock-Based Compensation Costs) (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | |||
Stock-based compensation costs | $ 71,755 | $ 55,407 | $ 15,815 |
Cost of revenue | |||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | |||
Stock-based compensation costs | 2,520 | 1,436 | 384 |
Research and development | |||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | |||
Stock-based compensation costs | 23,828 | 20,008 | 5,842 |
Sales and marketing | |||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | |||
Stock-based compensation costs | 17,196 | 14,106 | 3,084 |
General and administrative | |||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | |||
Stock-based compensation costs | $ 28,211 | $ 19,857 | $ 6,505 |
Financial income (expenses), _3
Financial income (expenses), net (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Component Of Other Non Operating Income Expense [Abstract] | |||
Bank charges and other financial expenses | $ (596) | $ (134) | $ (369) |
Amortization of discount and issuance costs of convertible notes | (2,527) | (20,029) | (4,036) |
Derivatives and hedging | (875) | 0 | 0 |
Exchange rate gain (loss), net | 1,141 | (1,273) | (262) |
Interest income | 6,481 | 1,923 | 1,867 |
Financial income (expenses), net | $ 3,624 | $ (19,513) | $ (2,800) |
Income taxes (Narrative) (Detai
Income taxes (Narrative) (Details) - USD ($) | 12 Months Ended | |||||||
Jan. 02, 2017 | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | Dec. 31, 2017 | Dec. 31, 2016 | |
Net Operating Losses (“NOL”) carryforward | $ 96,864 | |||||||
Corporate tax rate | 23% | 23% | 23% | 24% | 25% | |||
Federal statutory income tax rate | 7.50% | 9% | ||||||
Percent of federal statutory income tax rate, preferred enterprises located other than development area | 16% | |||||||
Percentage of federal statutory income tax rate of preferred technological enterprise income | 12% | |||||||
Percentage of effective income tax rate reconciliation | 35% | 21% | ||||||
Percentage of net operating loss deduction to taxable income | 80% | |||||||
Unrecognized Tax Benefits | $ 910,000 | |||||||
Income tax according to statutory tax rules outside of Israel | ||||||||
Net Operating Losses (“NOL”) carryforward | $ 75,695 | |||||||
Israel | ||||||||
Corporate tax rate | 23% | 23% | 23% | |||||
Minimum | ||||||||
Tax benefit period, commencement | 12 years | |||||||
Minimum | US | ||||||||
Open tax year | 2017 | |||||||
Minimum | Israel | ||||||||
Open tax year | 2017 | |||||||
Minimum | Foreign ownership | ||||||||
Reduced corporate tax rate company will be liable in years three to eight, based on the percentage of foreign ownership | 10% | |||||||
Maximum | US | ||||||||
Open tax year | 2022 | |||||||
Maximum | Israel | ||||||||
Open tax year | 2022 | |||||||
Maximum | Foreign ownership | ||||||||
Reduced corporate tax rate company will be liable in years three to eight, based on the percentage of foreign ownership | 25% |
Income taxes (Schedule of Domes
Income taxes (Schedule of Domestic and Foreign Loss Before Income Taxes) (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Loss before income taxes | $ (70,910) | $ (64,853) | $ (14,610) |
Domestic | |||
Loss before income taxes | (62,905) | (58,166) | (11,097) |
Foreign | |||
Loss before income taxes | $ (8,005) | $ (6,687) | $ (3,513) |
Income taxes (Schedule of Dom_2
Income taxes (Schedule of Domestic and Foreign Income Taxes) (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Income taxes | $ 577 | $ 159 | $ 200 |
Domestic | |||
Income taxes | 632 | 0 | 0 |
Foreign | |||
Income taxes | $ (55) | $ 159 | $ 200 |
Income taxes (Schedule of Defer
Income taxes (Schedule of Deferred tax assets) (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Deferred tax assets: | ||
Net operating loss carryforwards | $ 38,850 | $ 44,480 |
Research and development expenses carryforward | 3,989 | 2,262 |
Accrued and other | 7,369 | 1,630 |
Share-based compensation | 12,674 | 7,584 |
Operating lease liabilities | 2,173 | 1,033 |
Issuance costs | 0 | 630 |
Total deferred tax asset | 65,055 | 57,619 |
Deferred tax liabilities: | ||
Operating lease ROU assets | 2,097 | 998 |
Convertible notes | 102 | 17,275 |
Acquired Intangible assets | 1,060 | 2,253 |
Accrued and other | 17 | 603 |
Total deferred tax liability | 3,276 | 21,129 |
Total deferred tax assets, net | 61,779 | 36,490 |
Less-valuation allowance | (61,779) | (36,490) |
Total deferred tax assets, net of valuation allowance | $ 0 | $ 0 |
Income taxes (Schedule of Recon
Income taxes (Schedule of Reconciliation Theoretical Income Tax Expense to Actual Income Tax Expense) (Details) - USD ($) $ in Thousands | 12 Months Ended | ||||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2018 | Dec. 31, 2016 | |
Income Tax Disclosure [Abstract] | |||||
Loss before income taxes | $ (70,910) | $ (64,853) | $ (14,610) | ||
Statutory tax rate | 23% | 23% | 23% | 24% | 25% |
Theoretical tax benefit | $ 16,309 | $ 14,916 | $ 3,360 | ||
Increase (decrease) in effective tax rate due to: | |||||
Change in valuation allowance | (4,491) | (4,474) | (2,558) | ||
Effect of entities with different tax rates | (145) | (28) | (47) | ||
Non-deductible expenses | (12,433) | (11,501) | (2,964) | ||
Impact of different tax rate on temporary differences | 0 | (462) | (119) | ||
Excess tax benefit on stock based compensation | 593 | 1,562 | 2,178 | ||
Uncertain tax provision | (302) | 0 | 0 | ||
Other | (108) | (172) | (50) | ||
Effective income taxes | $ (577) | $ (159) | $ (200) |
Income taxes (Schedule of rec_2
Income taxes (Schedule of reconciliation of opening and closing amounts of total unrecognized tax positions) (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Income Tax Disclosure [Abstract] | ||
Opening balance | $ 393 | $ 221 |
Decrease related to previous years tax positions | (393) | 0 |
Increase related to previous years tax positions | 590 | 0 |
Increase related to current year tax positions | 843 | 172 |
Closing balance | $ 1,433 | $ 393 |
Segment and geographic inform_3
Segment and geographic information (Schedule of Geographic Areas Based on Location) (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Segment Reporting Information [Line Items] | |||
Revenues | $ 337,366 | $ 297,662 | $ 189,510 |
U.S. | |||
Segment Reporting Information [Line Items] | |||
Revenues | 172,704 | 154,360 | 100,706 |
Europe | |||
Segment Reporting Information [Line Items] | |||
Revenues | 84,484 | 77,019 | 48,331 |
Asia Pacific | |||
Segment Reporting Information [Line Items] | |||
Revenues | 48,585 | 38,437 | 22,814 |
Rest of the world | |||
Segment Reporting Information [Line Items] | |||
Revenues | 28,153 | 24,991 | 15,715 |
Israel | |||
Segment Reporting Information [Line Items] | |||
Revenues | $ 3,440 | $ 2,855 | $ 1,944 |
Segment and geographic inform_4
Segment and geographic information (Schedule of Long Lived Assets by Geographical Areas) (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Segment Reporting Information [Line Items] | ||
Long lived assets | $ 14,737 | $ 18,282 |
Israel | ||
Segment Reporting Information [Line Items] | ||
Long lived assets | 13,714 | 16,175 |
U.S. and other | ||
Segment Reporting Information [Line Items] | ||
Long lived assets | $ 1,023 | $ 2,107 |